日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
17(2)
日本癌治療学会 [編]
国立国会図書館雑誌記事索引 1 (1) 1966.03~;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行
Presidential Lecture Several Efforts to Conquer Cancer / Y.Hikasa / p217~217
Memorial Lecture 1.Eighteen Years in which Japan Society for Cancer Therapy has Traced / K.Nakayama / p218~218
Memorial Lecture 2.Retrospection on Surgery of Gastric Cancer / T.Kajitani / p219~219
Special Lecture 1.Hormone Receptors and Hormone-dependency of Cancer / K.Matsumoto / p220~220
Special Lecture 2.The Corticotropin-β-lipotropin Precursor Gene: Structure and Expression in Normal Neoplastic Tissues / S.Numa / p221~221
Special Lecture 3.Epidemiological Consideration on Cancer--Interaction of Host and Environment in Childhood / K.Aoki / p222~222
Special Lecture 4.Cloning of Human Tumor Stem Cells:Role in Cancer Treatment and New Drug Development / S.E.Salmon / p223~240
Special Lecture 5.Pancreatic Cancer / I.Cohn,Jr. / p241~249
Special Lecture 6.Localized Hyperthermia in the Treatment of Cancer / F.K.Storm / p250~281
Lecture Reco㎜ended by President A-1.Treatment for Malignant Ovarian Tumors / M.Yakushiji / p282~282
Lecture Reco㎜ended by President A-2.Transplacental Hormonal Carcinogenesis and Teratogenesis / K.Hoshino / p283~283
Lecture Reco㎜ended by President B-1.The Hereditary Neoplasm of the Large Bowel / J.Utsunomiya / p284~284
Lecture Reco㎜ended by President B-2.Some Problems in the Early Diagnosis of Colon Cancer / M.Tada / p285~285
Lecture Reco㎜ended by President C-1.TdT Activity and Vincristine-Prednisolone Therapy in Blast Crisis of Chronic Myelogenous Leukemia / S.Sakamoto et al. / p286~286
Lecture Reco㎜ended by President C-2.Microencapsulation of Anticancer Drugs and Its Clinical Application / T.Kato / p287~287
Lecture Reco㎜ended by President D-1.Immunochemotherapy with Transfer Factor for Primary Lung Cancer Patients / T.Fujisawa / p288~288
Lecture Reco㎜ended by President D-2.Tracheobronchial Plasty for Lung Cancer / M.Maeda / p289~289
Lecture Reco㎜ended by President E-1.Intraoperative Radiotherapy for Refractory Cancer / M.Abe et al. / p290~290
Lecture Reco㎜ended by President E-2.Single Photon Emission Computed Tomography / T.Maeda et al. / p291~291
Lecture Reco㎜ended by President F-1.The Phenomenon of Spontaneous Regression of Flat Warts / H.Tagami / p292~292
Lecture Reco㎜ended by President F-2.Functional Characteristic of Tumor Vessels,with Reference to Enhancement of the Drug Delivery / M.Suzuki / p293~293
Lecture Reco㎜ended by President G.Primary Reconstructive Surgery in Head and Neck Cancer--Evaluation of Long-term Survival Rate and Functional and Cosmetic Effect / A.Konno / p294~294
Symposium 1 Problems in Treatment of Malignancies of Pelvic Cavity / / p295~301
Symposium 1 1.The Problems in the Treatment of Cervical Cancer / H.Okuda / p295~295
Symposium 1 2.Surgical Treatment for Carcinoma of the Uterine Cervix / A.Suzuki / p296~296
Symposium 1 3.Problems on the Treatment of Malignant Tumors in the Pelvis--Bladder Tumor / K.Koiso / p297~297
Symposium 1 4.The Management of Bladder Cancer / O.Yoshida / p298~298
Symposium 1 5.Rectal Cancer--End Results and Functional Disturbances in Abdominoperineal Resection and Sphincter Saving Procedures with or without Extended Lymph Nodes Dissection / Y.Koyama / p299~299
Symposium 1 6.Treatment of Malignancies of the Intrapelvic Organ: Carcinoma of the Rectum / K.Kato / p300~300
Symposium 1 7.Problems in Treatment for Malignant Tumors in the Pelvis / S.Mochizuki / p301~301
Symposium 2 Present Status of Mass-screening in Japan / / p302~310
Symposium 2 1.Mass-screening of Uterine Cancer in Chiba Prefecture / T.Kasai / p302~302
Symposium 2 Utterance Results in Cytology Mass-screening of the Uterine Cancer by Tobo Method / T.Hasegawa / p303~303
Symposium 2 2.Current Problems in Mass Screening for Breast Cancer / K.Yoshida / p304~304
Symposium 2 3.Mass Screening Program for Prostatic Cancer by Means of Transrectal Ultrasonotomography / H.Ohe / p305~305
Symposium 2 Utterance Cytologic Examination of the Urine as a Mass Screening of the Urinary Bladder Cancer / T.Yamada / p306~306
Symposium 2 4.The Present Aspect of a Mass Screening for Lung Cancer / J.Tamada / p307~307
Symposium 2 Utterance Results of a Long Term Lung Cancer Survey / Y.Hayata / p308~308
Symposium 2 5.Mass Survey for Stomach Cancer / K.Tamura / p308~309
Symposium 2 Utterance Mass Screening for Colorectal Cancer / S.Kobayashi / p309~309
Symposium 2 6.Results and Some Problems of Mass Screening of Neuroblastoma in Infancy / T.Sawada / p310~310
Symposium 3 Problems in Primary Liver Cancer / / p311~319
Symposium 3 1.Pathological Considerations on Hepatocellular Carcinoma / M.Okudaira et al. / p311~311
Symposium 3 2.Pathology of Hepatocellular Carcinoma--A Study of Histological Growth Pattern and Tumor Vessels / T.Nakashima et al. / p312~312
Symposium 3 Utterance Hepatocellular Carcinoma with or without Liver Cirrhosis / W.Mori / p313~313
Symposium 3 3.High Risk Group of Liver Cell Carcinoma / N.Hattori et al. / p313~313
Symposium 3 4.Not Received / /
Symposium 3 Utterance Diagnostic Significance of Hepatoma Specific Gamma-Glutamyltranspeptidase / K.Fujisawa et al. / p314~314
Symposium 3 5.Angiographic Diagnosis of Hepatoma and Its Application for Transarterial Treatment / K.Hiramatsu et al. / p314~315
Symposium 3 6.Not Received / /
Symposium 3 Utterance Embolization of Hepatoma Findings on Follow-up CT with Evaluation of Tumor and Liver Volume / S.Furui et al. / p315~315
Symposium 3 7.Operative Results of Hepatic Lobectomy for Primary Hepatoma / K.Sugahara et al. / p316~316
Symposium 3 8.The Present Status of Surgical Treatments of Hepatoma in our Clinic / E.Okamoto / p317~317
Symposium 3 Utterance Aggressive Surgery and Postoperative Support against Liver Cancer / H.Hasegawa / p318~318
Symposium 3 9.Viral Hepatitis and Hepatoma / K.Nishioka / p319~319
Symposium 5 8.Perspective of Cancer Chemotherapy / K.Kimura / p331~332
Symposium 5 9.Radiotherapy in Future / Y.Umegaki / p332~332
Panel Discussion Local Therapy against Recurrence of Cancer / / p333~340
Panel Discussion 1.Cryosurgery and Cryochemotherapy for the Treatment of Local Recurrent Cancer / S.Tanaka / p333~333
Panel Discussion 2.Clinical Experience with Thermotherapy to Recurrent Malignant Tumors after Radiotherapy / M.Hiraoka et al. / p333~333
Panel Discussion 3.Laser Surgery for the Local Recurrence Cases of Head and Neck Tumors / M.Nakata et al. / p334~334
Panel Discussion 4.Therapeutic Results of Wide Resection in Recurrent Cancer of the Head and Neck / M.Uchida / p334~334
Panel Discussion 5.Hematoporphyrin Derivative and Laser Photoradiation in the Treatment of the Metastatic Skin Lesion from Breast Cancer / H.Kato et al. / p335~335
Panel Discussion 6.Reconstructive Method of Anterior Chest Wall after Wide Resection--Evaluation of the Usefulness of Acrylic Resin / S.Noguchi / p335~335
Panel Discussion 7.The Treatment of Recurrent Esophageal Cancer / S.Onoda et al. / p336~336
Panel Discussion 8.Effect of a Slow-Releasing Anticancer Agent(Solid Bleomycin Tube)on Recurrent Metastatic Lymph Nodes / H.Watanabe et al. / p336~336
Panel Discussion 9.Resection of Locally Recurred Cancer of the Stomach / K.Miwa et al. / p337~337
Panel Discussion 10.Intratumoral Large-dose Administration of OK-432 in Patients with Recurrent Gastric Cancer / M.Niimoto et al. / p337~337
Panel Discussion 11.Continuous Hyperthermic Peritoneal Perfusion for the Patients with Peritoneal Dissemination / M.Maeta et al. / p338~338
Panel Discussion 12.Endoscopic Cryosurgery for Recurrent Gastric Cancer / T.Yamasaki et al. / p338~338
Panel Discussion 13.Clinical Application of Microencapsulated Anticancer Drug: V.Antitumor Effect on Locally Recurrent Carcinoma in Pelvis / R.Nemoto et al. / p339~339
Panel Discussion 14.A New Approach with the Combined Therapy for Recurrent Gynecological Malignancies: A Trial of Thermochemotherapy and Cryochemotherapy / I.Kohno et al. / p339~339
Panel Discussion 15.Balloon Occluded Arterial Infusion of Anticancer Drug for Recurrent Carcinoma / H.Nakatsuka et al. / p340~340
Workshop Diagnosis and Treatment for Cancer--Its Blind Spots / / p341~428
Workshop1 Biochemical Assays / / p341~347
Workshop1 1.Usefulness of 5'-Nucreotide Phosphodiesterase Isoenzyme-V(5'-NPD-V)for Diagnosing Liver Metastasis / M.Nakada et al. / p341~341
Workshop1 2.Not Received / /
Workshop1 3.A Simple Enzymatic Assay for Diamines and Polyamines and Its Clinical Application / T.Matsumoto et al. / p341~341
Workshop1 4.α2-PA Glycoprotein as a Parameter in Diagnosis and Clinical Course of Lung Cancer / H.Maruishi et al. / p342~342
Workshop1 5.Pregnancy-associated α2-glycoprotein in Patients with Ovarian Cancer / Y.Shimizu et al. / p342~342
Workshop1 6.The Use of CEA Slope Analysis as an Indicator of Early Recurrence in Patients with Gastrointestinal Breast Carcinoma / S.Akai et al. / p343~343
Workshop1 7.Early Detection of Recurrent Gastric Cancer by Serum CEA Level / R.Tamada et al. / p343~343
Workshop1 8.Diagnostic Evaluation of Carcinoembryonic Antigen in Pleural Fluid / M.Takada et al. / p344~344
Workshop1 9.Clinical Significance of Bile CEA Level in the Diagnosis of Malignant Biliary and Pancreatic Diseases / Y.Watanabe et al. / p344~344
Workshop1 10.Severe Nephropathy Induced by the Deposition of CEA-immune Complex / T.Mori et al. / p345~345
Workshop1 11.Pitfalls in Ferritin Assay in Malignancy and Its countermeasurement / Y.Kohgo et al. / p345~345
Workshop1 12.Evaluation of Alpha-fetoprotein as the Tumor Marker in the Clinical Course of 44 Non-seminomatous Testicular Tumors / M.Yanagisawa / p346~346
Workshop1 13.Significance of Basic Fetoprotein in Uro-genital Disease: Clinical Usefulness as a Testicular Tumor Marker / H.Nagata et al. / p346~346
Workshop1 14.Diagnosis of Choriocarcinoma Using Radioimmunological Measurement of B-hCG,SP1 and PP5 / T.Saito et al. / p347~347
Workshop1 15.Diagnostic Value in Malignant Digestive Disease Using Three Kinds of Tumor Markers,Basic Fetoprotein(BFP),Carcinoembryonic Antigen(CEA),Alpha-Fetoprotein(AFP) / Y.Kanda et al. / p347~347
Workshop2 Imaging Examination / / p348~355
Workshop2 1.Pitfalls of Medical Imagings--Diagnostic Modalities in Recognizing Hepatoma / K.Kawahira et al. / p348~348
Workshop2 3.Ultrasonographic Findings of Hepatoma,Particularly in Minute Hepatoma / Y.Majima et al. / p349~349
Workshop2 4.Significance of Ultrasonography in the Early Stage of Hepatocellular Carcinoma / A.Saitoh et al. / p349~349
Workshop2 5.Clinical Usefulness and Limitation of Emission Computed Tomography for Detecting Small Liver Tumors / K.Yamamoto et al. / p350~350
Workshop2 6.Pitfalls in Diagnostic imaging of Hepatoma and Carcinoma of the Bifurcation of the Hepatic Ducts / S.Iida et al. / p350~350
Workshop2 7.Evaluation of Image Diagnostic Modalities in Laparotomized Patients for Hepatectomy--Intraoperative Ultrasonic Examination(10-US),Preoperative Ultrasonic Examination(P-US),CT and Angiography / M.Makuuchi et al. / p351~351
Workshop2 8.Preoperatively Staging of Gastric Cancer Using Image Diagnostic Tools such as CT and US / M.Ozaki et al. / p351~351
Workshop2 9.Criteria for the Assessment of Chemotherapy of Borrmann Type 4 Gastric Cancer / M.Kurihara et al. / p352~352
Workshop2 10.CT as a Quide to the Operation of the Recal Carcinoma / Y.Tsujinaka et al. / p352~352
Workshop2 11.Diagnostic Imaging of Bile Duct Carcinoma / S.Shimaguchi et al. / p353~353
Workshop2 12.The Pitfall of the Radiological Diagnosis for Bile Duct Cancer and Percutaneous Transhepatic Cholangioscopy (PTCS) / Y.Nimura et al. / p353~353
Workshop2 13.Pitfalls in Sonographic Diagnosis of Pancreatic Cancer / T.Miyashita et al. / p354~354
Workshop2 14.Evaluation of Diagnostic Procedure of CT in the Kidney / B.Suyama et al. / p354~354
Workshop2 15.Comparison of Computed Tomography and Angiography in the Evaluation of Renal Cell Carcinoma / T.Onishi et al. / p355~355
Workshop2 16.Diagnosis of Ovarian Tumor by Ultrasonography,Computerized Tomography and Scintigraphy / S.Doi et al. / p355~355
Workshop3 Chemotherapy--Leukemia / / p356~360
Workshop3 1.Evalution of Prognostic Factors and Risk Point Scoring System of Children with Acute Lymphoblastic Leukemia / K.Iguchi et al. / p356~356
Workshop3 2.High-dose Methotrexate with Citrovorum Factor Rescue in Refractory Adult Acute Lymphocytic Leukemia / Y.Fujiwara et al. / p356~356
Workshop3 3.BH-AC・AMP Combination Chemotherapy of Patients with Acute Nonlymphocytic Leukemia in Relapse / H.Suzuki et al. / p357~357
Workshop3 4.A Pilot Study Using High Doses of Daunomycin and Cytosine Arabinoside for Induction Therapy of AML / H.Taguchi et al. / p357~357
Workshop3 5.Action Mechanism of Aclacinomycin A(ACM) in Leukemic Cells and Its Clinical Effects / T.Nakamura et al. / p358~358
Workshop3 6.Prophylactic Chemotherapy for Acute Blastic Transformation of Chronic Myelocytic Leukemia / K.Okada et al. / p358~358
Workshop3 7.Chemotherapy for the Blastic Crisis in CML / K.Kitajima et al. / p359~359
Workshop3 8.Schedule Dependency in Combination Chemotherapy with Ara C Group and Anthracycline Group / Y.Sakai et al. / p359~359
Workshop3 9.Hemostatic Abnormalities in Hematopoietic Malignancy: Chemotherapy and DIC / M.Kuto et al. / p360~360
Workshop3 10.Therapy of Erythroleukemia and RAEM / H.Sawada et al. / p360~360
Workshop4 Chemotherapy--SolidCancer / / p361~368
Workshop4 1.Chemotherapy of Head and Neck Cancer--Recent Progress and Prospect / Y.Inuyama et al. / p361~361
Workshop4 2.Results of Summary of the Controlled Study in the Chemotherapy of a Small Cell Bronchogenic Carcinoma in Lung Cancer Chemotherapy Groups of National Hospitais and Sanatorium / H.Komatsu et al. / p361~361
Workshop4 3.Brain Metastasis of Small Cell Lung Cancer--Retrospective Analysis of Prophylactic Brain Radiation / Y.Nakata et al. / p362~362
Workshop4 4.Pitfalls of Chemotherapy for Inoperable Non-small Cell Lung Cancer / M.Kawahara et al. / p362~362
Workshop4 5.Chemotherapy for Advanced Lung Cancer--Response and Prognostic Factors / M.Fukuoka et al. / p363~363
Workshop4 6.Postoperative Chemotherapy in Gastric Cancer--With MFC Therapy as the Predominance / H.Sato et al. / p363~363
Workshop4 7.UFTM-chemotherapy for Gastric Cancer / S.Suga et al. / p364~364
Workshop4 8.Disease State Representation and Prediction of Prognoses for Advanced Gastric Cancer Patients / H.Takahashi et al. / p364~364
Workshop4 9.A Study of Adjuvant Chemotherapy at Time of Operation for Colo-rectal Cancer,Especially Subserosal Administration Method / A.Yagita et al. / p365~365
Workshop4 10.Treatment of Hepatocellular Carcinoma by Intra-arterial One Shot Injection of Anticancer Drugs / K.Hirai et al. / p365~365
Workshop4 11.Changes of the Tumor Vesseles Following Intra-arterial Infusion Therapy Using a Combination of Mitomycin and Dexamethazone / K.Satomura et al. / p366~366
Workshop4 12.Effect of Cancer Chemotherapy for Unresectable Cancer of the Pancreas / Y.Kinami et al. / p366~366
Workshop4 13.Brain Metastasis and Damage of Spermatogenesis during Combination Chemotherapy for Disseminated Germinal Cell Carcinoma of the Testis / T.Kiriyama et al. / p367~367
Workshop4 14.Clinical Results of Induced Hypertension Chemotherapy with Angiotensin II / Y.Sato et al. / p367~367
Workshop4 15.High Dose Combination Chemotherapy with Autologous Bone Marrow Transplantation in Cancer Patients / A.Hiraiwa et al. / p368~368
Workshop5 Multimodulated Therapy Combined with Surgery--Brain and Neck / / p369~380
Workshop5 1.The Effects of Fibroblast Interferon(F-IF)on the Transplanted Human Malignant Gliomas to the Nude Mice and on the Clinical Cases / Y.Miki et al. / p369~369
Workshop5 2.Interferon Therapy on Malignant Brain Tumors--Special Reference to the Intratumorous and Intrathecal Administration / M.Nagai et al. / p369~369
Workshop5 3.Extensive Surgical Removal of Glioblastoma after Radiotherapy / M.Matsutani et al. / p370~370
Workshop5 4.Preoperative Radiotherapy and Radical Removal of Malignant Brain Tumors / T.Kondo et al. / p370~370
Workshop5 5.High-dosage BCNU and Autologous Bone Marrow Grafting for Pediatric Brain Tumors / K.Kuwamura et al. / p371~371
Workshop5 6.Multimodality Treatment of Malignant Glioma,Effect of Immunotherapy with N-CWS / J.Yoshida et al. / p371~371
Workshop5 7.ACNU and PSK Therapy after the Surgical Treatment of the Malignant Intracranial Tumors (Especially Cases of Long Term Survival) / K.Muraoka et al. / p372~372
Workshop5 8.Clinical Application of Iridium-192 in Recurrent Glioma / K.Nomura et al. / p372~372
Workshop5 9.Comparative Study of Multimodality Treatment for Malignant Brain Tumors / K.Harada et al. / p373~373
Workshop5 10.Assessment of Surgical Treatment Combined with Chemotherapy for Cerebral Metastasis of Choriocarcinoma / T.Ishizuka et al. / p373~373
Workshop5 11.The Diagnosis and Treatment of Brain Metastasis of Lung Cancer--Correlation between Histological Types and CT Findings / T.Kobayashi et al. / p374~374
Workshop5 12.Problems of Multidisciplinary Treatment of Cancer in the Head and Neck / K.Sugita et al. / p374~374
Workshop5 13.Combined Therapy for Maxillary Sinus Carcinoma,with Special Reference to Contribution of Surgery / S.Sakai et al. / p375~375
Workshop5 14.Results and Changes of Our Combined Therapy for Maxillary Cancer / H.Saito et al. / p375~375
Workshop5 15.Reconsideration of the Combined Treatment by Surgery,Chemotherapy and Radiation for Cancer of the Maxillary Sinus / Y.Matsumura et al. / p376~376
Workshop5 16.A Combined Therapy of Surgery,Radiotherapy, Regional Chemotherapy and BCG Immunotherapy in Cancer of the Maxilla / H.Takahashi et al. / p376~376
Workshop5 17.Pitfall of the Diagnosis and Treatment for Undifferentiated Carcinoma of the Thyroid Gland / Y.Tanaka et al. / p377~377
Workshop5 18.The Choice of Treatment in Thyroid Carcinoma with the Lower Transformation: If You Find the Poorly Differentiated or Anaplastic Transformation of Thyroid Carcinoma,How do You Treat Them? / N.Kasai et al. / p377~377
Workshop5 19.Resection of Thyroid Carcinoma Infiltrating the Trachea / T.Ishihara et al. / p378~378
Workshop5 20.Surgical Salvage of Radiation Failures in the Treatment of Carcinoma of the Tongue / I.Ono. / p378~378
Workshop5 21.Some Remarks on a Combination Therapy of Hypopharyngeal Cancer / Y.Murakami et al. / p379~379
Workshop5 22.Post-laryngectomy Tracheal Stomal Recurrence Following Emergency Tracheostomy / S.Komiyama et al. / p379~379
Workshop5 23.New Surgical Trial for Carcinoma of the Tongue Base / K.Sugimoto et al. / p380~380
Workshop 6 Multimodulated Therapy Combined with Surgery--Thorax and Breast / / p381~389
Workshop 6 1.Study on Operative Cases of Mediastinal Tumor,Especially Treatment of Malignant Mediastinal Tumor Combined with Operation / M.Imaizumi et al. / p381~381
Workshop 6 2.PostoPerative Prognosis of the Surgically Treated Patients with Primary Adenocarcinoma of the Lung with Mediastinal Lymph Node Metastases / S.Fukai et al. / p381~381
Workshop 6 3.Adjuvant Therapy of Lung Cancer / K.Kunishima et al. / p382~382
Workshop 6 4.Post-operative Chemotherapy for Lung Cancer--In vivo Sensitivity Test of Anti-cancer Drugs and Their Effective Concentration in the Peripheral Blood / M.Kitano et al. / p382~382
Workshop 6 5.Anticancer Chemotherapy Adjunct to the Resection of Lung Cancer / E.Akaogi et al. / p383~383
Workshop 6 6.Results of Adjuvant Therapy of 4,931 Cases with Lung Cancer--Results of Field Study in Japan / K.Yoshimura et al. / p383~383
Workshop 6 7.Hematoporphyrin Derivative(HpD)and Laser Photoradiation in the Treatment of Lung Cancer / C.Konaka et al. / p384~384
Workshop 6 8.The Evaluation of Surgical Treatment Combined with Chemotherapy for Pulmonary Metastases of Choriocarcinoma / Y.Nishikawa et al. / p384~384
Workshop 6 9.Not Received / /
Workshop 6 10.A New Operative Method of Extended Radical Mastectomy and an Analysis of Its 43 Performed Cases / M.Noguchi et al. / p385~385
Workshop 6 11.Problems in Prophylactic Irradiation for Mammary Carcinoma and Some Trials to Improve Patient's Prognosis / Y.Koike et al. / p385~385
Workshop 6 12.Adjuvant Chemotherapy with Modified CMF Combination for Breast Cancer / Y.Uekita et al. / p386~386
Workshop 6 13.Combined Therapy on Stage III Breast Cancer and Its Therapeutic Policy in Our Department / T.Ueda et al / p386~386
Workshop 6 14.Surgical Adjuvant Chemotherapy for Breast Cancer / T.Morimoto et al. / p387~387
Workshop 6 15.Prognostic Factors and Adjuvant Therapy in Cancer of the Breast with 8 or More Involved Axillary Nodes / S.Miura et al. / p387~387
Workshop 6 16.Multidisciplinary Treatment for Locally Advanced Breast Cancer / H.Koyama et al. / p388~388
Workshop 6 17.Non-specific Immunity of Breast Cancer Patients and Effect of Levamisole(LMS)& Krestin(PSK)Using with Post-operative Adjuvant Chemotherapy in Breast Cancer Patients / K.Hoshino et al. / p388~388
Workshop 6 18.Immune Responses in the Treatment of Advanced Carcinoma of the Breast Effect of Adreno-oophorectomy / M.Akimoto et al. / p389~389
Workshop 7 Multimodulated Therapy Combined with Surgery--Esophagus and Abdomen / / p390~395
Workshop 7 l.Adjuvant Cancer Chemotherapy for Carcinoma of the Esophagus / K.Sugimachi et al. / p390~390
Workshop 7 2.The Effect of Fast Neutron as a Combined Therapy for Esophageal Carcinoma / K.Isono et al. / p390~390
Workshop 7 3.Multidisciplinary Treatment for Esophageal Carcinoma / T.Iizuka et al. / p391~391
Workshop 7 4.Effects of Pre-operative Irradiation Combined with Intra-tumor Injection of Pepleomycin(PLM)and BUdR(5-bromodeoxy-uridine)on Growth and Survival in a Mouse Fibrosarcoma, and on Advanced Human Carcinoma of the Rectum in Lower Portion / T.Todoroki et al. / p391~391
Workshop 7 5.Surgery and Combination Therapy in Esophageal Cancer Cases with Special Reference to Postoperative Prophylactic Irradiation of the Neck and Upper Mediastinum / H.Ide et al. / p392~392
Workshop 7 6.Clinical Studies of Resected Esophageal Carcinoma Following Radiation Therapy of Over 5,000 Rad / H.Koizumi et al. / p392~392
Workshop 7 7.Extension of Upper Gastric Carcinoma and Operative Procedure / Y.Omori et al. / p393~393
Workshop 7 8.Is a Splenectomy an Useful Method in an Operation for a Gastric Cancer? / K.Yoshino et al. / p393~393
Workshop 7 9.Chemo-endocrine Therapy for Diffuse Carcinoma of the Stomach / H.Kitaoka et al. / p394~394
Workshop 7 10.Continuous Hyperthermic Peritoneal Perfusion(CHPP)for Prevention of Peritoneal Dissemination / N.Shimizu et al. / p394~394
Workshop 7 11.Combined Therapy of Surgical Treatment of the Extra Hepatic Bile Duct Cancer / T.Kobayashi et al. / p395~395
Workshop 7 12.Problems in Treatment for Hepatic Cancer--Anticancer Treatment with Oily Anticancer Drug Injected into the Hepatic Artery / S.Tashiro et al. / p395~395
Workshop 7 13.Not Received / /
Workshop 8 Multimodulated Therapy Combined with Surgery--Urogenital Organ / / p396~399
Workshop 8 1.Evaluation of Treatment for Renal Cell Carcinoma / F.Masuda et al. / p396~396
Workshop 8 2.Pitfall in the Multidisciplinary Treatment for High Stage Cancer of the Urinary Bladder / M.Miyakawa et al. / p396~396
Workshop 8 3.Clinical Studies on Recurrence Rate of Superficial Bladder Tumor by Intravesical Instillation / A.Maru et al. / p397~397
Workshop 8 4.Combination Chemotherapy,Radiation Therapy and Surgery for Testicular Cancer / S.Noda et al. / p397~397
Workshop 8 5.Surgical Procedures for Preventing Urological Complications Following Radical Hysterectomy / M.Matsuzawa et al. / p398~398
Workshop 8 6.Surgical Chemotherapy for Advanced Uterine Cervival Cancer / M.Iwasaki et al. / p398~398
Workshop 8 7.Combination Therapy with Radical Hysterectomy in Cancer of Uterine Cervix / H.Noguchi / p399~399
Workshop 8 8.The Effects of Reduction Surgery and Chemotherapy on Patients with Advanced Ovarian Cancer / M.Yasuda et al. / p399~399
Workshop 9 Multimodulated Therapy Combined with Surgery--Skin,Bone and Soft Tissue / / p400~406
Workshop 9 1.Surgical and Combined Treatment of Malignant Melanoma / K.Ishihara et al. / p400~400
Workshop 9 2.Primary Malignant Melanoma of the Head and Neck--An Experience of 11 Cases / K.Omura et al. / p400~400
Workshop 9 3.Practical Multidisciplinary Therapy for Skin Squamous Cell Carcinoma,Incorporating Peplomycin(PEP)and Bestatin / H.Miyasato et al. / p401~401
Workshop 9 4.Laser Surgery of Carcinoma of the Skin / K.Hishimoto et al. / p401~401
Workshop 9 5.Adriamycin Ointment for Treatment of Recurrent Carcinoma / M.Fukuda et al. / p402~402
Workshop 9 6.Three Cases of Ectopic Breast Carcinoma / M.Ishigaki et al. / p402~402
Workshop 9 7.Prognostic Factors in Osteosarcoma / K.Furuse et al. / p403~403
Workshop 9 8.En Bloc Resection for Osteosarcoma / N.Matsui et al. / p403~403
Workshop 9 9.The Studies on the Wide Resection for Limb Preservation Combined with Pre-operative Intra-arterial Infusion of Anti-cancer Agents in Osteosarcoma / S.Takeuchi et al. / p404~404
Workshop 9 10.Clinical Study of Limb Saving Operation for Osteosarcoma / S.Higaki et al. / p404~404
Workshop 9 11.Surgery,Radiotherapy and Chemotherapy for Ewing's Sarcoma / S.Takeyama et al. / p405~405
Workshop 9 12.Malignant Giant Cell Tumor of Bone / S.Toriyama et al. / p405~405
Workshop 9 13.Six Cases of Malignant Giant-cell Tumor of Bone / S.Yamawaki et al. / p406~406
Workshop 10 Radiation Therapy / / p407~414
Workshop 10 1.Precision Radiation Treatment Planning System (Application of CT to Radiation Treatment Planning System) / T.Iwata et al. / p407~407
Workshop 10 2.Radiotherapy Planning with CT Scan for Prostatic Carcinoma / K.Hayakawa et al. / p407~407
Workshop 10 3.Application in Computer Reconstruction Technique for Conformation Radiotherapy Planning / T.Ishigaki / p408~408
Workshop 10 4.Precision Conformation Radiotherapy Using the Modified,Multileaved Collimators / Y.Tanaka et al. / p408~408
Workshop 10 5.Radiation Therapy for the Local Recurrence of Breast Carcinoma and the Effect of Chest Wall Lymphatic Drainage / S.Matsubara et al. / p409~409
Workshop 10 6.Tissue Tolerance Limit of Radiotherapy for Carcinoma of the Oral Cavity and Treatment of Radiation Injuries / M.Nakano et al. / p409~409
Workshop 10 7.Afterloading Small Source Irradiation Technique for Lesions in Deep-seated Organs / M.Kakehi / p410~410
Workshop 10 8.Clinical Experience with Fast Neutron Therapy Utilizing High Intensity Californium-252 Sources / T.Dokiya et al. / p410~410
Workshop 10 9.Inhibition of Potentially Lethal Damage(PLD)Repair: Its Implication in Radioresistant Tumor Therapy / S.Nakatsugawa et al. / p411~411
Workshop 10 10.Experience of Radiotherapy Combined with Hypoxic Cell Radiosensitizer,Misonidazole / K.Ono et al. / p411~411
Workshop 10 11.Combined Chemoradiotherapy for Malignant Brain Tumors / H.Yamamoto et al. / p412~412
Workshop 10 12.Several Fractionation Protocols in Case of Combined Radiotherapy with Polychemotherapy / H.Asakura et al. / p412~412
Workshop 10 13.Studies on Immunological Parameters in the Cancer Patients under Chemotherapy and Immunotherapy Report5: T and B Cells and Lymphoblastogenesis / T.Komita et al. / p413~413
Workshop 10 14.An Opinion of Preoperative Irradiations for the Advanced Cancers / S.Mikuriya et al. / p413~413
Workshop 10 15.Role of Intravenous Hyperalimentation(IVH)in Radiotherapy of Carcinoma of the Esophagus / M.Takahashi et al. / p414~414
Workshop 11 Immunotherapy / / p415~424
Workshop 11 1.Effect of C.Parvum and Poly ICLC on Experimentary Brain Tumor--Comparison between Local Administration and General Administration / K.Kiya et al. / p415~415
Workshop 11 2.Post-operative Immunotherapy with OK-432 for Oral Cancer Patients / H.Adachi et al. / p415~415
Workshop 11 3.Immunological Treatment of the Head and Neck Cancer / E.Yamamoto et al. / p416~416
Workshop 11 4.Evaluation of Multidisciplinary Treatments Against Bladder Cancer II. Variations of Non-specific Immunoparameters in Maintenance Therapy(P.S.K.+CQ) / Y.Nakagami et al. / p416~416
Workshop 11 5.The Prognosis of the Uterine Cervical Cancer Patients Treated by Radiotherapy Combined with PSK / T.Kasamatsu et al. / p417~417
Workshop 11 6.The Pitfall of Immunotherapy in Children with All / H.Akane et al. / p417~417
Workshop 11 7.Successful Remission Maintenance Immunotherapy by OK-432 in Malignant Lymphoma / S.Shirakawa et al. / p418~418
Workshop 11 8.Immunotherapy of Hematological Malignancies with Krestin / T.Nagao et al. / p418~418
Workshop 11 9.Serological Analysis of Melanoma Patients Immunized with Autologous Melanoma Cells / T.Watanabe et al. / p419~419
Workshop 11 10.Serum Immunosuppressive Factors as Parameters of Cell-mediated Immunity in Cancer Patients during Immunotherapy / K.Ishitani et al. / p419~419
Workshop 11 11.A New Protocol of Passive Immunotherapy with Tumor Specific Immune RNA / M.Fukushima et al. / p420~420
Workshop 11 12.Combination Chemoimmunotherapy for Gastric Carcinoma / M.Kawaguchi et al. / p420~420
Workshop 11 13.A Large Dose of OK-432 Immunotherapy in Gastric Cancer Patients Undergoing Absolute Non Curative Resection / T.Toge et al. / p421~421
Workshop 11 14.Preoperative Local Immunotherapy Immunomorphological Evaluation of Host Response at Primary Gastric Carcinomas and Their Regional Lymph Nodes Induced by Intratumoral Injection of OK-432 / Y.Kodama et al. / p421~421
Workshop 11 15.Immunotherapy with OK-432,Streptococcus Pyogens Preparation,for Cancer Patients--Correlations between the Change of Immunological Response and the Survival Period / H.Hanaue et al. / p422~422
Workshop 11 16.Study of the Immune Response in the Cancer Patients by the Longterm Intravenous Administration of OK-432 / A.Kawamura et al. / p422~422
Workshop 11 17.The Study on Intraarterial Immunochemotherapy Using Lentinan / M.Ryu et al. / p423~423
Workshop 11 18.Effects on Tumor Growth of Various Immunopotentiators in Splenectomized Tumor-bearing Rats Experimental Study Using a Rat's Mammary Tumor,MRMT-1 / S.Saji et al. / p423~423
Workshop 11 19.Splenectomy and Immunotherapy for the Treatment of Advanced Gastric Cancer / H.Miwa et al. / p424~424
Workshop 11 20.Pitfall of Immunotherapy of Inoperable Advanced Gastric Cancer--With Special References of Induction of Suppressor T Cells / S.Koyama et al. / p424~424
Workshop 12 Malignant Tumors in Childhood / / p425~428
Workshop 12 1.Pitfalls in Diagnosis of Neuroblastoma and in Treatment of Wilms'Tumor / H.Tsunooka et al. / p425~425
Workshop 12 2.Critical Evaluation of Urinary Vanilmandelic Acid(VMA)and Homovanillic Acid(HVA)as Tumor Markers for Neuroblastoma / K.Yokomori et al. / p425~425
Workshop 12 3.Results of Surgical Treatment with Adjuvant Chemotherapy for Advanced Neuroblastoma (Stage III&IV) / S.Ogita et al. / p426~426
Workshop 12 4.Rapid Growth of Metastatic Tumors after Second-look Operation among Patients with Advanced Neuroblastoma / T.Matsuda et al. / p426~426
Workshop 12 5.Treatment of Advanced Abdominal Neuroblastoma--Significance of Metastatic Lymph Nodes for Recurrence / J.Uchino et al. / p427~427
Workshop 12 6.A Problem on Radiotherapy for Pulmonary Metastases of Wilms'Tumor / N.Ohnuma et al. / p427~427
Workshop 12 7.Not Received / /
Workshop 12 8.Late Manifestation of Occult Blood Born Metastases / K.Nagashima et al. / p428~428
General Lecture 1.Changes in Cystoscopical Growth Pattern of Recurrent Bladder Tumors / T.Takesue et al. / p429~429
General Lecture 2.Growth Kinetics of Human Gastric and Colon Carcinoma Transplanted in the Nude Mice / K.Bando et al. / p429~429
General Lecture 3.Correlations between Preoperative Administration of Anti-cancer Agents against Human Digestive Organ Cancers and Its Transplantability to Nude Mice / E.Kawamura et al. / p430~430
General Lecture 4.Heterotransplantation of the Human Carcinomas into Nude Mice / K.Sakuramoto et al. / p430~430
General Lecture 5.Cell Surface Antigens of Human Melanoma Detected by Monoclonal Antibody / K.Nishiyama et al. / p431~431
General Lecture 6.The Specific Red Cell Adherence Test and Bladder Cancer / H.Takigawa et al. / p431~431
General Lecture 7.Inhibition of Tumor Cells and Platelets in Formation of Tumor Thrombs / T.Ishii et al. / p432~432
General Lecture 8.Local Fibrinolytic Activity and Inhibitory Activity of Human G-I Tract Cancer Tissues--Comparison between Esophageal,Gastric and Colon Cancers / M.Sato et al. / p432~432
General Lecture 9.A Study of Granulocytosis in a Patient of Primary Pancreatic Carcinoma / T.Ishii et al. / p433~433
General Lecture 10.Transitory Reduction of Blood Pressure Due to Metastatic Cervical Node Cancer / S.Takoda et al. / p433~433
General Lecture 11.Impaired Glucose Metabolism and Its Related Hormone Environment in Endometrial Cancer / K.Kuzuya et al. / p434~434
General Lecture 12.Studies on the Concomitant Infections in Cancer Patients Treated in Our Clinic / S.Okubo et al. / p434~434
General Lecture 13.Index of Immunological and Nutritional Status in Cancer Patients (Cancerous Cachexy Index:CCI) / M.Sato et al. / p435~435
General Lecture 14.Postoperative Death of Gastric Cancer Patients,with Special Reference to the Surgery-associated Death and Multiple Organ Failure / T.Nakajima et al. / p435~435
General Lecture 15.Experimental Studies Concerning the Antitumor Effect in the Lymph Node of Tumor Bearing Host / H.Matsumoto et al. / p436~436
General Lecture 16.Effects of Adult Thymectomy on the Growth of 203-glioma in Mice / T.Yamasaki et al. / p436~436
General Lecture 17.Studies on Thymus Lymphocytes from Rat with BBN Induced Bladder Tumor(First Report)Effect of Calf Thymus Humoral Factor on In Vitro Con A Response of Thymus Lymphocytes / S.Wada et al. / p437~437
General Lecture 18.Stimulatory Effect of 2-mercaptoethanol on Tumor Bearers with Suppressed Immune Status and Its Therapeutic Effect / Y.Kikuchi et al. / p437~437
General Lecture 19.Effects on Tumor Metastasis of Operative Stress by Tumor Excision and Laparotomy Experimental Analysis Using a Rat's Mammary Tumor,MRMT-1 / T.Takekoshi et al. / p438~438
General Lecture 20.Immunological Function and Effect of Chemotherapy in Protein-Calorie Deficient Mice / M.Akimoto et al. / p438~438
General Lecture 21.Specific Cell-mediated Immunity in Patients with Cervical Cancer / H.Mori et al. / p439~439
General Lecture 22.Induction of Specific Immune Lymphocytes against Autologus Tumor Cells / H.Kimura et al. / p439~439
General Lecture 23.On Clinical Features of the Cases in which Cytotoxicity was Evidenced with Mixed Lymphocyte-autotumor Cell Culture / S.Yamamoto et al. / p440~440
General Lecture 24.Evaluation of Specific S.I. in Patients with Bladder Carcinoma / S.Nishio et al. / p440~440
General Lecture 25.Effect of Surgery on Cell-mediated Immunity in Cancer Patients / S.Miyazaki et al. / p441~441
General Lecture 26.Not Received / /
General Lecture 27.Natural Killer Activity in Intracranial Tumor Bearing Mice and Patients with Brain Tumors / S.Otsuka et al. / p441~441
General Lecture 28.Distribution of Natural Killer Activity in Gastric Cancer Patients / Y.Moritani et al. / p442~442
General Lecture 29.A Study on Natural Killer Cell Activity in the Patients with Cancer of Digestive Tract / H.Matsumoto et al. / p442~442
General Lecture 30.Studies on Natural Killer Activity in Cancer Patients / K.Senba et al. / p443~443
General Lecture 31.Dissociation of Natural Killer Activity and Affinity of Subpopulations of Peripheral Lymphocytes in Cancer Patients and Normal Donors / T.Matsui et al. / p443~443
General Lecture 32.Prognostic Value of NK Activity and ADCC in Tumor-bearing Patients / N.Irimajiri et al. / p444~444
General Lecture 33.Study on the Changes of Immune Reactivities during Maintenance Therapy for Uterine Cancer / T.Kanda et al. / p444~444
General Lecture 34.Changes of Immune Status of Breast Carcinoma Patients after the Topical Administration of Emulsionized 5-fluorouracil (5-Fu) / G.Katsuki et al. / p445~445
General Lecture 35.Immune Status of Breast Cancer Patients before and after Operation / Y.Haga et al. / p445~445
General Lecture 36.Cell-mediated Immunological Dynamics after Operation about the Patients with the Gastric Cancer / Y.Fuyuhiro et al. / p446~446
General Lecture 37.The Postoperative Immunity in the Gastric Cancer,and Its Change with the Anti Cancer Agents Administration / K.Ishiyama et al. / p446~446
General Lecture 38.All-round Estimation of Cellular Immunity of Cancer Patients and of Effectiveness of Immunopotentiators by Using of Several Routine Parameters of Lymphocytes / T.Shimbo et al. / p447~447
General Lecture 39.As for the Dynamics of Peripheral Eosinocytes in Patients with Gastric Cancer / T.Fujii et al. / p447~447
General Lecture 40.Peripheral Blood Monocyte Count & Monocyte Function in Gastric Cancer Patient / T.Yamane et al. / p448~448
General Lecture 41.Skin Reactivity to PHA and PPD in Sick and Healthy Persons / S.Shimada et al. / p448~448
General Lecture 42.Correlations between Renal Carcinoma Patients and PPD,PHA Skin Test / M.Hata et al. / p449~449
General Lecture 43.Effect of Lung Cancer Operations on Postoperative Cellular Immunity / T.Sakai et al. / p449~449
General Lecture 44.Comparative Study of Immune Competence of Breast Cancer Patients between in Positive Estrogen Receptor Cases and in Negative Cases / A.Kimoto et al. / p450~450
General Lecture 45.Immunological Behavior and Prognosis of Patients with Cancer of the Head and Neck / K.Fujii et al. / p450~450
General Lecture 46.Not Received / /
General Lecture 47.General Immunocompetence in Gastric and Colorectal Cancer Patients / E.Yasui et al. / p451~451
General Lecture 48.Not Received / /
General Lecture 49.The Significance of Human T Cells Bearing IgG-Fc Receptor in the Patients with Bladder Tumor / T.Fujiwara et al. / p451~451
General Lecture 50.Changes of ADCC Activity,IgG Fc R⁺T-cell(Tγ)and T,B Subpopulation of Invasive Cervical Cancer Patients during Treatment with or without OK-432 / M.Hatae et al. / p452~452
General Lecture 51.Immunosuppressive Acidic Protein in Patients with Head and Neck Cancer / A.Kida et al. / p452~452
General Lecture 52.The Clinical Significance of Serum Immunosuppressive Acidic Protein in the Patients of Recurrent Gastric Cancer / S.Kikuchi et al. / p453~453
General Lecture 53.Immunosuppressive Acidic Protein (IAP) in Biliary Tract and Pancreatic Cancer Patients / Y.Osaki et al. / p453~453
General Lecture 54.Serum Levels of Immunosuppressive Acidic Protein in Patients with Cervical Cancer / S.Shiraki et al. / p454~454
General Lecture 55.The Relationship between the Serum Level of Immunosuppressive Acidic Protein and Clinical Status of Gynecologic Malignancies / T.Saito et al. / p454~454
General Lecture 56.Significance of Immunosuppressive Acidic Protein (IAP) Measurement on the Gynecologic Malignancies / M.Takeda / p455~455
General Lecture 57.Serum Levels of an Immunosuppressive Acidic Protein in Patients with Gynecological Cancer / H.Suzuki et al. / p455~455
General Lecture 58.Study of Serum Inhibitory Factor in Patients with Head and Neck Malignancy / K.Sakaguchi et al. / p456~456
General Lecture 59.Tumor Immunity in Thyroid Carcinoma: Correlation between Immunosuppressive Substance (ISS) and Anti-thyroid Antibody / A.Sugenoya et al. / p456~456
General Lecture 60.Studies on Humoral Immunoregulatory Factors in Gastric Cancer Patients / K.Nakanishi et al. / p457~457
General Lecture 61.Immunosuppressive Substance (ISS) in the Serum of Patients with Colonic Cancer / S.Fuchimoto et al. / p457~457
General Lecture 62.Immune Response Suppression by Ascitic Fluid of Patient with Gastrointestinal Cancer / K.Amemiya et al. / p458~458
General Lecture 63.Recurrent Breast Cancer Treated with Chest Wall Reconstruction after Local Excision / Y.Uyama et al. / p458~458
General Lecture 64.Pathologic Identification of Breast Cancer Patients with High Risk of Recurrence after Radical Mastectomy / T.Nakamura et al. / p459~459
General Lecture 65.A Study of the Postoperative Recurrent Cases of Breast Cancer / T.Asagoe et al. / p459~459
General Lecture 66.Study of Therapeutic Result for Local Breast Cancer / H.Yamashita et al. / p460~460
General Lecture 67.The Analysis of the Causes of Death more than 5 Years after Mastectomy and Treatment of Recurrence or Metastasis from Breast Cancer / T.Sakurai et al. / p460~460
General Lecture 68.The Correlation between the Incidences of Lymphatic Metastases and the Sites of Tumors / T.Kusano et al. / p461~461
General Lecture 69.Prognosis of 81 Patients Operated Curatively for n₂(+)Gastric Cancer / K.Azekura et al. / p461~461
General Lecture 70.The Prognosis of Early Gastric Cancer in the Middle Third of Stomach and Their Lymph Nodes Metastasis at Operation / H.Furukawa et al. / p462~462
General Lecture 71.A Study of Early Gastric Cancer--Specially Centered to Lymph Node Metastases / A.Misao et al. / p462~462
General Lecture 72.Leukemoid Reaction and Bone Marrow Metastasis of the Gastric Cancer / S.Harashima et al. / p463~463
General Lecture 73.Clinical and Statistical Study of Factors Affecting Prognosis in Esophageal Cancer / Y.Arai et al. / p463~463
General Lecture 74.Postoperative Prognosis of the Esophageal Cancer with No Lymphatic Involvement / Y.Sannohe et al. / p464~464
General Lecture 75.Histologic Characteristics of a Small Carcinoma of the Stomach with Hepatic Metastasis / O.Kimura et al. / p464~464
General Lecture 76.Histologic Characteristics of Early Recurrent Cases of Gastric Cancer after Curative Gastrectomy / H.Nishidoi et al. / p465~465
General Lecture 77.Natural Time History of Endometrial Cancer / R.Tsunematsu et al. / p465~465
General Lecture 78.Statistical and Immunological Studies on Recurrent Cancer of the Uterine Cervix / S.Katashima et al. / p466~466
General Lecture 79.A Study on Risk Factors Concerned with Lymph Node Metastasis of Uterine Cervical Cancer / Y.Tsukahara et al. / p466~466
General Lecture 80.Lymphography and Prognosis of Cervical Cancer Clinical Value of Unusual Opacification of Mediastinal,Cervical and Axillar Lymphnodes / J.Ito et al. / p467~467
General Lecture 81.A Case of Uterine Cervical Carcinoma who Had Wide-spread Bony Metastases / T.Kotani et al. / p467~467
General Lecture 82.A Case of Stage Ia Carcinoma of the Uterine Cervix with Lymph Node Metastasis / Y.Kato et al. / p468~468
General Lecture 83.Metastasis of Transitional Cell Carcinoma of the Upper Urinary Tract / G.Nakada et al. / p468~468
General Lecture 84.Examination on Post-operative Metastasis of Bladder Cancer / K.Numasawa et al. / p469~469
General Lecture 85.Analysis of 57 Autopsy Cases of Bladder Cancer / K.Tashiro et al. / p469~469
General Lecture 86.Clinical Evaluation of the Treatment for Disseminated Testis Tumor--Combined Modality of Chemotherapy and Cytoreductive Surgery / T.Tsukamoto et al. / p470~470
General Lecture 87.Combined Therapy for Metastatic Lung Cancer from the Testicular Tumor / S.Mikuriya et al. / p470~470
General Lecture 88.Prognostic Analysis of Malignant Pleural and Peritoneal Effusions / S.Yamada et al. / p471~471
General Lecture 89.Malignant Pericarditis by Bronchogenic Carcinoma / T.Shinkai et al. / p471~471
General Lecture 90.A Trial of Combined Modality Therapy for Malignant Pericarditis / K.Okabe et al. / p472~472
General Lecture 91.Studies on the Gastric Cancer Patients with Intraperitoneal Free Cancer Cells / Y.Iitsuka et al. / p472~472
General Lecture 92.Cytology,Colposcopy and Colposcopic Target Biopsy to the Early Diagnosis of the Uterine Cervical Cancer--The Correlation between These Diagnostic Methods and the Final Diagnosis / S.Yoh et al. / p473~473
General Lecture 93.Studies on Preoperative Diagnosis of Early Cervical Carcinoma--Concerning Reduction of Diagnostic Cone Biopsy / T.Horii et al. / p473~473
General Lecture 94.Needle Aspiration Cytology in Diagnosis of Breast Tumors / F.Nagata et al. / p474~474
General Lecture 95.Aspiration Cytology in the Diagnosis of Breast Cancer with Special Regard to the Influence upon Prognosis / Y.Nishizawa et al. / p474~474
General Lecture 96.Urinary Cytology in Patients with Urothelial Tumor / K.Suzuki et al. / p475~475
General Lecture 97.Cytological Screening of Urinary Tract Cancer in Combination with Routine Urinalysis / R.Abe et al. / p475~475
General Lecture 98.Vascular Involvement in Mainly T₁ Carcinoma of the Tongue / T.Matsushima et al. / p476~476
General Lecture 99.The Fine Angioarchitecture of Corpus Uteri / Y.Nakagiri et al. / p476~476
General Lecture 100.Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases (VII) -On Local Lymphocyte Infiltration and Immunological Alteration of Long Survival Cases of Cancer Patients- / S.Nakagawa et al. / p477~477
General Lecture 101.T Lymphocytes in Cancer Tissues of the Head and Neck Regions An Immunohistochemical Investigation / T.Furusaka et al. / p477~477
General Lecture 102.Stromal Reaction in Bladder Tumor (4th Report) -The Role of Local Lymph Follicles and Immunoblastoid Cells- / R.Yasumoto et al. / p478~478
General Lecture 103.A Study on Perifocal Stroma in Cervical Cancer / T.Sano et al. / p478~478
General Lecture 104.Cytohistochemical Studies on the Estrogen Receptor of Mammary Tissues in Mammary Carcinoma and Other Diseases by the Immunoperoxidase Method / K.Matsumoto et al. / p479~479
General Lecture 105.Histochemical Study on Androgen Binding Protein of Cancerous Prostate / T.Matsumura et al. / p479~479
General Lecture 106.Immunohistochemical Localization of Prostatic Acid Phosphatase(P.A.P.)in Prostatic Cancer / K.Endo et al. / p480~480
General Lecture 107.Polyamine Levels in Tissues of Colorectal Carcinoma / J.Miyata et al. / p480~480
General Lecture 108.A Comparative Study of Histochemical Patterns of CEA and Mucins in Gastric Cancer / T.Tanioku et al. / p481~481
General Lecture 109.Tissue Carcinoembryonic Antigen in Colorectal Cancer / H.Tomoda et al. / p481~481
General Lecture 110.Immuno Histological Staining of Tumor Marker and Correlations between Tissue Level and Serum Level of CEA in Resectable and Unresectable Pancreatic Cancer Patients / T.Amemiya et al. / p482~482
General Lecture 111.Tissue Localization of Immunoglobulin,Carcinoembryonic Antigen(CEA)and Human Chorionic Gonadotropin(HCG)in Carcinoma of the Uterine Cervix / M.Kawamoto et al. / p482~482
General Lecture 112.Clinical Studies of Carcinofetal Proteins in Carcinoma of the Uterine Cervix Immunohistochemically / N.Kadomoto et al. / p483~483
General Lecture 113.Follow-up Study of the Leukoplakia of the Oral Cavity / A.Inoue et al. / p483~483
General Lecture 114.Studies on Surface Roughness of Carcinoma of the Oral Mucosa / T.Amagasa et al. / p484~484
General Lecture 115.The Clinical Features of Minute and Small Thyroid Carcinoma / N.Kasai et al. / p484~484
General Lecture 116.Statistical Studies on Registrated Thyroid Cancer Patients in Japan / S.Ebihara et al. / p485~485
General Lecture 117.Statistical Evaluation of Neck Masses--Evaluation of Ultrasonography in Differential Diagnosis of Neck Masses / M.Miyata et al. / p485~485
General Lecture 118.Cervical Tumors / K.Furukawa et al. / p486~486
General Lecture 119.Facial Nerve Paralysis in Parotid Gland Tumors / T.Kato et al. / p486~486
General Lecture 120.A Clinicopathologic Study on the Patient Survived more than 10 Years after Operation for Advanced Gastric Cancer / A.Sakuma et al. / p487~487
General Lecture 121.Clinicopathological Analysis of Early Gastric Carcinoma--An Analysis of 217 Cases / M.Sowa et al. / p487~487
General Lecture 122.A Study on Cancer of Large Bowel in the Early Stage / A.Sato et al. / p488~488
General Lecture 123.A Clinicopathological Study of Fourteen Cases with Perforated Gastric Cancer / S.Kondo et al. / p488~488
General Lecture 124.Not Received / /
General Lecture 125.Clinical Studies on the Prognosis of Non-resectable Gastric Cancer / H.Oshibuchi et al. / p489~489
General Lecture 126.Clinicopathological Study on Palliative Resection of Colorectal Carcinoma / S.Tabuchi et al. / p489~489
General Lecture 127.Histo-pathology and Clinical Study on Stage"Shallow Ib"Carcinoma of Uterine Cervix / K.Taoka et al. / p490~490
General Lecture 128.The Significances of Histological Typing for Cervical Carcinoma / T.Inoue et al. / p490~490
General Lecture 129.A Clinicopathologic Study for 9 Patients with Extramammary Paget's Disease of the Vulva / S.Kodama et al. / p491~491
General Lecture 130.A Pathological Study of the Correlation between Mitotic Count and the Prognosis of Ovarian Cancer / H.Nishimura et al. / p491~491
General Lecture 131.Not Received / /
General Lecture 132.Clinical and Pathological Analysis of Germ Cell Tumors of the Ovary / T.Miyazaki et al. / p492~492
General Lecture 133.Studies on Bladder Tumor in 36 Cases less than 40 Years Old / T.Tochigi et al. / p492~492
General Lecture 134.Clinical Analysis of the Bladder Tumor according to General Rule on Bladder Cancer / K.Okada et al. / p493~493
General Lecture 135.Clinical Analysis of 155 Bladder Cancer Patients with Special Reference to the Prophylactic Instillation Therapy / T.Misaki et al. / p493~493
General Lecture 136.Clinico-pathological Study of Renal Cell Carcinoma / T.Murase et al. / p494~494
General Lecture 137.Not Received / /
General Lecture 138.Not Received / /
General Lecture 139.Malignant Schwannoma with Prolonged Fever,Anemia and Hypergammaglobulinemia / K.Hashimoto et al. / p494~494
General Lecture 140.Pediatric Malignancies in the Head and Neck / M.Horiuchi et al. / p495~495
General Lecture 141.Treatment for Liver Cell Carcinoma in Infants and Children--In Special Reference to Histological Problems / A.Toyosaka et al. / p495~495
General Lecture 142.The Mass Screening Campaign for Breast Cancer in Kanagawa Prefecture(The Second Report) / N.Tamura et al. / p496~496
General Lecture 143.Mass Screening for Breast Cancer / Y.Nakano et al. / p496~496
General Lecture 144.Mass Screening of Breast Cancer in Miyagi Prefecture / R.Abe et al. / p497~497
General Lecture 145.Not Received / /
General Lecture 146.11 Years Experience with Mass Screening for Breast Cancer in Tokushima Prefecture / F.Nishiyama et al. / p497~497
General Lecture 147.Experience of Mass Screening of Neuroblastoma in Infants / H.Tsunooka et al. / p498~498
General Lecture 148.Mass Screening for Colorectal Cancer Using Fecal Occult Blood Testing / M.Fujita et al. / p498~498
General Lecture 149.The Result of Mass Screening for Cervical Cancer in Miyagi Prefecture / S.Sato et al. / p499~499
General Lecture 150.The Present Status and Problems Relative to Group Examinations for Uterine Cervix Cancer in Fukushima Prefecture / K.Niitsuma et al. / p499~499
General Lecture 151.Report of 15 Multiple Primary Cancers in Our Department / H.Kamata et al. / p500~500
General Lecture 152.Diagnosis,Treatment and Prognosis of Double Primary Cancers / S.Tanimura et al. / p500~500
General Lecture 153.Study of Double Primary Malignant Neoplasm in Our Clinic / M.Kita et al. / p501~501
General Lecture 154.Multiple Primary Carcinomas of Esophagus and Other Organs / H.Shibuya et al. / p501~501
General Lecture 155.Clinical Study of Primary Multiple Cancers / M.Furukawa et al. / p502~502
General Lecture 156.Application of Low Cytometry to the Evaluation of the Effect by Chemotherapy in Gynecological Malignancies / M.Sugita et al. / p502~502
General Lecture 157.Study on High Risk Cases of Cervical Carcinoma after Treatment Assessed by Prospective Analysis / T.Maeda et al. / p503~503
General Lecture 158.Scale Transformation for Analysis of Cancer Survival Curves / S.Maetani et al. / p503~503
General Lecture 159.Analysis of the Prognostic Factors for Non-Hodgkin's Lymphoma by the Cox Regression Life Table Method / K.Tajima et al. / p504~504
General Lecture 160.Management of Data on Treating Cancer Patients Utilizing Microcomputer / K.Kaneta et al. / p504~504
General Lecture 161.Multi-image Diagnosis in Thyroid Tumors / Y.Takahashi et al. / p505~505
General Lecture 162.Clinical and Experimental Studies on the Diagnostic Methods of the Breast Diseases--With Special References to the Score System / A.Nakano et al. / p505~505
General Lecture 163.The Significance of the Ultrasonography and the Deep Body Thermometer as a Supplementary Diagnostic Method for the Breast Cancer / K.Tohyama et al. / p506~506
General Lecture 164.About Ultrasonography of the Breast Tumor / K.Nagano et al. / p506~506
General Lecture 165.The Use of Echolaparoscope on the Diagnosis of Hepatobiliary Malignancies / M.Fukuda et al. / p507~507
General Lecture 166.Diagnostic Tomography for Prostatic Carcinoma / Y.Sawamura et al. / p507~507
General Lecture 167.Follow-up Study of NPC Cases Using Computed Tomography / K.Harada et al. / p508~508
General Lecture 168.Evaluation of CT Diagnosis for the Extent of Primary Lung Cancer / T.Yusa et al. / p508~508
General Lecture 169.Hepatic Artery Occlusion (Transcatheter Embolization and Ligation) in Hepatomas,Assessed by Computed Tomography and α-fetoprotein Value in the Serum Following Angiography / T.Sugiu et al. / p509~509
General Lecture 170.Not Received / /
General Lecture 171.Screening Use for Detecting Lymphnodes Metastasis of Cervical Cancer by Using Radio-isotope(RI) Lymphography / T.Fujita et al. / p509~509
General Lecture 172.Lymphography and Lymphoscintigraphy in Urogenital Cancers / N.Saito et al. / p510~510
General Lecture 173.Local Findings of Renal Cell Carcinoma on Scintigraphic Modalities / J.Kawamura et al. / p510~510
General Lecture 174.Measurement of Regional Effective Hepatic Blood Flow Using¹⁹⁸Au-colloid / H.Mimura / p511~511
General Lecture 175.Estimation of Clinical Efficacy for Scintigraphic Images of Liver / K.Machida et al. / p511~511
General Lecture 176.Significance of Microcalcification on Mammographic Diagnosis of Early Breast Cancer / T.Ohashi et al. / p512~512
General Lecture 177.Not Received / /
General Lecture 178.Effect of Combined Bleomycin Mitomycin C Chemotherapy for Lung Metastasis of Cervical Cancer Evaluated by Tumor Volume Ratio / Y.Matsuura et al. / p521~512
General Lecture 179.Usefulness of Pyeloureteroscopy(Ureterorenoscopy)in the Diagnosis of Malignant Tumors of the Upper Urinary Tract / Y.Aso et al. / p513~513
General Lecture 180.Role of Serum Markers(Human Chorionic Gonadotropin and Alpha-fetoprotein)in the Manage-ment of Testicular Germ Cell Tumors / M.Hagiwara et al. / p513~513
General Lecture 181.Urinary HCG of Patients with Malignant Tumors Treated with Radiotherapy / T.Nakano et al. / p514~514
General Lecture 182.Sequential Assay System of hCG Including hCG-β C-Terminal Peptide(hCG-βCTP)Assay for the Management of Trophoblastic Diseases / Y.Ashitaka et al. / p514~514
General Lecture 183.Characteristics of Anti-hCGβ-Carboxyl-Terminal Peptide Sera and Its Application in the Clinical Management of Trophoblastic Diseases / S.Matsuura et al. / p515~515
General Lecture 184.Ectopic Alpha Subunit of Human Chorionic Gonadotropin Producing Tumor / N.Morimoto et al. / p515~515
General Lecture 185.Studies on CEA in Tissue and Blood, Relating to Diagnosis, Therapeutic Effect and Prognostic Prediction in Ovarian Cancer / T.Oosaki et al. / p516~516
General Lecture 186.Clinical Evaluation of Serum CEA Levels in Uterine Cervix Cancer with Radiotherapy / Y.Kikuchi et al. / p516~516
General Lecture 187.Correlations between Serum Glycoprotein and Carcinoembryonic Antigen(CEA)in Patients with Gastric Cancer / K.Morita et al. / p517~517
General Lecture 188.The Usefulness of the Changing Rate of Serum Carcinoembryonic Antigen(CEA)during Anticancer Therapy of the Pancreatic Carcinoma / O.Ishikawa et al. / p517~517
General Lecture 189.Clinical Meanings of CEA in the Treatment of Cancer of Large Intestine / S.Takashima et al. / p518~518
General Lecture 190.Serum Ferritin Levels in Gynecologic Malignant Diseases / T.Arai et al. / p518~518
General Lecture 191.Tumor Markers in Renal Cancer Patients / H.Hisazumi et al. / p519~519
General Lecture 192.A Clinical Evaluation of Serum Ferritin as a Tumor Marker of Lung Cancer / Y.Ariyoshi et al. / p519~519
General Lecture 193.Markers in Hormone Dependent Tumors (I.Thyroid and Breast Cancers) / T.Tabei et al. / p520~520
General Lecture 194.The Amount of Concanavalin A Non-reactive Alpha-fetoprotein in Yolk Sac Tumor and Other Hepatic Lesions / Y.Tsuchida et al. / p520~520
General Lecture 195.Urinary Hydroxyproline Excretion as a Marker of Bone Metastases in Prostatic Cancer` / K.Rinsho et al. / p521~521
General Lecture 196.Clinical Studies on Radioimmunoassay of Prostatic Acid Phosphatase / Y.Ohmi et al. / p521~521
General Lecture 197.Total Sialic Acid and Lipid Bound Sialic Acid in the Sera of Cancer Patients / S.Oki et al. / p522~522
General Lecture 198.Diagnosis and Treatment of Head and Neck Cancer Using Urinary Biochemical Markers / T.Hotate et al. / p522~522
General Lecture 199.Detection of Liver Metastases with 5'Nucleotide Phosphodiesterase Isoenzyme-V in Human Gastric Cancer / M.Kitajima et al. / p523~523
General Lecture 200.Thyroglobulin Measurement with Radioimmunoassay in Plasma of Patients with Various Thyroid Disease: Its Usefulness and Problems in Monitoring the Activity of Thyroid Adenocarcinoma / N.Aoki et al. / p523~523
General Lecture 201.Experimental Analysis about the Cause of Increased Serum RNase / C.Fujimori et al. / p524~524
General Lecture 202.The Significance of Serum Lysozyme Activity in Patients with Cancer / M.Hakosaki et al. / p524~524
General Lecture 203.Clinical Uses of Cisplatin for Gynecological Malignant Tumors / M.Ikeda et al. / p525~525
General Lecture 204.Chemotherapy of Malignant Ovarian Tumors--Therapeutic Results of Cisplatin / K.Yamashita et al. / p525~525
General Lecture 205.Combination Chemotherapy with Cis-dichlorodiamine Platinum and the Other Agents for Ovarian and Tubal Cancer / M.Fukuoka et al. / p526~526
General Lecture 206.Pathologically Followed Anti-cancer Effect of Cis-platinum Based Combined Chemotherapy for Recurrent Ovarian Cancer / H.Fukuoka et al. / p526~526
General Lecture 207.Chemotherapy of Ovarian Adenocarcinoma with Cisplatin and Adriamycin / N.Tsukamoto et al. / p527~527
General Lecture 208.Phase II Trial with Cisplatin in Ovarian Malignancies / H.Ito et al. / p527~527
General Lecture 209.Combination Chemotherapy with Cis-dichlorodiammineplatinum(II)in Disseminated Testicular Cancer / T.Miki et al. / p528~528
General Lecture 210.CDDP Combination Chemotherapy for Non-seminomatous Testicular Cancer / Y.Akasaka et al. / p528~528
General Lecture 211.The Chemotherapy Using CDDP for Advanced Urogenital Malignancy / K.Miyakoda et al. / p529~529
General Lecture 212.Cis-diammine Dichloroplatinum(CDDP)Combination Chemotherapy for Advanced Urogenital Malignancies / G.Hamami et al. / p529~529
General Lecture 213.Combination Chemotherapy with Cis-platinum,Ifosfamide and Adriamycin in Patients with Advanced Urogenital Cancer / J.Yoshimoto et al. / p530~530
General Lecture 214.A Post Mortem Studied in a Case of Complete Regression Advanced Lung Cancer with Combined MAF Plus Cis-platinum Chemotherapy / T.Tatsumura et al. / p530~530
General Lecture 215.Chemotherapy for Squamous Cell Carcinoma--Evaluation of Combination Therapy with Cisplatin and Bleomycin / T.Sasaki et al. / p531~531
General Lecture 216.Suppressive Effect of Cis-diamminedichloroplatinum on Natural Killer Cell Activity / T.Hara et al. / p531~531
General Lecture 217.Clinical Experience with Cis-diamminedichloroplatinum(II) / M.Suzuki et al. / p532~532
General Lecture 218.The Clinical Study of the Cis-platinum(CDDP)on Single-agent or Combination Chemotherapy / T.Goto et al. / p532~532
General Lecture 219.Combination Chemotherapy of Cyclophosphamide,Adriamycin and Cis-diamminedichloroplatinum (II) ,CAP Therapy for Advanced Various Malignancies / S.Meguro et al. / p533~533
General Lecture 220.Peplomycin for Prostatic Cancer / N.Ohta et al. / p533~533
General Lecture 221.Continuous Drip Infusion of Peplomycin in Penile Cancer / T.Obama et al. / p534~534
General Lecture 222.Combined Therapy of Esophageal Cancer with Pepleomycin(MK631)and Radiation. / H.Kashimura et al. / p534~534
General Lecture 223.Pepleomycin in the Treatment of Refractory Malignant Lymphomas / M.Tanaka et al. / p535~535
General Lecture 224.Effect of Pepleomycin(PLM)on Prlmary Lung Cancer and Metastatic Pulmonary Tumor / N.Saijo et al. / p535~535
General Lecture 225.A Clinical Trial of a New Mitomycin C Derivative,7-N-(P-hydroxyphenyl)-mitomycinC(KW-2083) / M.Yokoyama et al. / p536~536
General Lecture 226,Clinical Study of KW-2083:A Derivative of Mitomycin C / M.Oride et al. / p536~536
General Lecture 227.Pilot Study of KW2083 / A.Urata et al. / p537~537
General Lecture 228.Clinical Evaluation of KW2083 / I.Nishi et al. / p537~537
General Lecture 229.Clinical and Experimental Studies on K-247,a New Synthesized Antitumor Agent / K.ogoshi et al. / p538~538
General Lecture 230.Clinical Studies of a New Synthesized Anticancer Agent (K-247) / K.Terabe et al. / p538~538
General Lecture 231.Effect of K-247 in Combination with Cancer Immunochemotherapy / T.Mori et al. / p539~539
General Lecture 232.Phase II Study of Ethyl(±)-t-6-butoxy-5-fluoro-2,4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278) / Y.Koyama et al. / p539~539
General Lecture 233.A Combination Chemotherapy with ACNU and DTIC for Malignant Melanoma / M.Domyo et al. / p540~540
General Lecture 234.Clinical Evaluation of Ifesfamide(Z4942)in Malignant Bone and Soft-tissue Tumors by Multiclinic Co-operative Study / Y.Akahoshi et al. / p540~540
General Lecture 235.The Pilot Study of BH-AC as an Adjuvant Chemotherapy / Y.Fujita et al. / p541~541
General Lecture 236.Phase II Clinical Study of Vindesine / H.Majima / p541~541
General Lecture 237.Preventive Effect of Antihistaminics against Pulmonary Fibrosis with Bleomycin / K.Furushima et al. / p542~542
General Lecture 238.Administration of Anticancer Agents in Combination with Hemoperfusion Over Charcoa / J.Yamagata et al. / p542~542
General Lecture 239.Efficacy of Kallidinogenase in Combined Chemotherapy for Cancer / A.Uematsu et al. / p543~543
General Lecture 240.Studies on the Pharmacodynamics of Tegafur(FutrafulR)Combined with Cytochrome-C / Y.Katsura et al. / p543~543
General Lecture 241.Antineoplastic Effect of 5-Fluorocytosine(5-FC)and Cytosine Deaminase (CDase) / T.Nishiyama et al. / p544~544
General Lecture 242.Experimental Study of FAM-R Therapy for the Mouse Tumor / K.Okada et al. / p544~544
General Lecture 243.Not Received / /
General Lecture 244.Experimental Studies on Intraluminal Administration of 5-FU Emulsion as an Adjuvant Chemotherapy to the Surgical Treatment of Gastrointestinal Cancer / K.Yahata et al. / p545~545
General Lecture 245.Inhibition of Murine Colon Adenocarcinoma 38 by Indomethacin Treatment / M.Sato et al. / p545~545
General Lecture 246.Possible Prevention from the Progression of Cardiotoxicity in Adriamycin-treated Rabbits by Coenzyme Q₁₀ / T.Usui et al. / p546~546
General Lecture 247.In vitro and in vivo Evaluation of Antitumer Activity of Aclacinomycin A and Adriamycin against Rat Urinary Bladder Tumor / Y.Kamiryo et al. / p546~546
General Lecture 248.Effects of Cis-DDP,Vincristin,and Neocarzinostatin on the Development of Urinary Bladder Tumors Induced by N-Butyl-N(4-Hydroxybutyl)Nitrosamine in Rats / S.Ohara et al. / p547~547
General Lecture 249.Continuous Bladder Instillation Therapy of Mitomycin-C on the Transplanted Urinary Bladder Cancer Using Osmotic Mini-pump / H.Akaza et al. / p547~547
General Lecture 250.Intravesioal Instillation of Cis-diamminedichloroplatinum (CDDP) / Y.Hirao et al. / p548~548
General Lecture 251.Effect of the Combination of Cisplatinum and Peplomycin on Ehrlich Ascites Carcinoma / S.Mashino et al. / p548~548
General Lecture 252.Not Received / /
General Lecture 253.Pharmacokinetics of 1-hexylcarbamoyl-5-fluorouracil (HCFU) / H.Fujita et al. / p549~549
General Lecture 254.Pharmacokinetics of UFT on Human Malignant Brain Tumors / K.Harada et al. / p549~549
General Lecture 255.Effect of UFT in Malignant Glioma (Part 1) -Concentration of FT-207 and 5-FU in Glioma Bearing Rat- / H.Nogaki et al. / p550~550
General Lecture 256.Study on Absorption of 5-FU Tablet / T.Kamano et al / p550~550
General Lecture 257.Study on Attainability of Oral 5-FU to Gynecological Cancer / K.Hattori et al. / p551~551
General Lecture 258.Clinical and Pharmacological Examination of Tegaful Continuous Intravenous Injection Therapy / T.Takasaki et al. / p551~551
General Lecture 259.5-FU Concentration in Various Tissue of the Patients Received FT-207 Prior to Operation / H.Sarashina et al. / p552~552
General Lecture 260.Preoperative Rectal Administration of FT-207 in Rectal Cancer / K.Hayashida et al. / p552~552
General Lecture 261.Concentration of FT-207 in Blood and Female Genital Tissues after Rectal Administration (I)--Correlation between Concentration in Blood and Tissues / H.Okazaki et al. / p553~553
General Lecture 262.Concentration of 5-FU Value in the Tissue and Blood of Breast Cancer Patients by Preoperative Administration of UFT / K.Suemasu et al. / p553~553
General Lecture 263.Clinical Study on Drug Delivery into Tumor Tissue by Using UFT / S.Arima et al. / p554~554
General Lecture 264.Intra-arterial Infusion of Adriamycin for the Treatment of the Locally Advanced Breast Cancer--Studies on the Concentration of Adriamycin in Serum, Normal Breast Tissues, Tumor Tissues and Lymph Nodes / Y.Takatsuka et al. / p554~554
General Lecture 265.Failure to Augment the Tissue Concentration of Adriamycin by Simultaneous Use of Urokinase / O.Izuno et al. / p555~555
General Lecture 266.Effects of BLM Administrated by Iontophoresis on Uterine Cervical Cancer / K.Koike et al. / p555~555
General Lecture 267.Effect of TCUK on Penetration of 5-FU into Tumor / H.Takada et al. / p556~556
General Lecture 268.Studies of the Concentration in the Tumor, Blood,and Abdominal Organs on the Combined Therapy with Tegafur and 5-FU / Y.Ashida et al. / p556~556
General Lecture 269.Histologic Effects of Oral Tegafur Administration in Gastric Cancer / J.Fujimoto et al. / p557~557
General Lecture 270.The Concentration of 5-FU Derivatives FD-I-E and THFU in Plasma and Stomach Tissue from Patients with Gastric Cancer / T.Ohno et al. / p557~557
General Lecture 271.Effect of DONU on Nine Human Carcinomas Transplanted to Nude Mice / F.Asanuma et al. / p558~558
General Lecture 272.Effect of Bleomycin and Pepleomycin(NK-631)to the Poorly Differentiated Transitional Cell Carcinoma Transplantable to the Nude Mice(NM-B-1) / N.Tsuboi et al. / p558~558
General Lecture 273.Antitumor Effects of Cis-platinum on Human Rhabdomyosarcoma Transplanted in Nude Mice / S.Masuda et al. / p559~559
General Lecture 274.A Study on Histopathological Changes of Testis by Cis-platinum Diamine Dichloride(CDDP)in Nude Mice Inoculated with Human Testicular Tumor / M.Tanino et al. / p559~559
General Lecture 275.Sensitivity of CDDP against Human Urogenital Malignant Neoplasms Transplantable to Nude Mice and Its Clinical Effects / M.Akimoto et al. / p560~560
General Lecture 276.Effect of Antitumor Agents against Human Tumor Xenografts Serially Transplanted to Nude Mice with Special Reference to Microangiography and Tumor Growth Rate / M.Okazaki et al. / p560~560
General Lecture 277.Sensitivity Test of Anticancer Agents of Human Hepatocellular Carcinoma Serially Transplanted to Nude Mice--With Special Reference to Difference in Sensitivity of Anticancer Agents to Three Strains / M.Kasajima et al. / p561~561
General Lecture 278.Sensitivity Test of Anticancer Agents of Human Hepatocellular Carcinoma Serially Transplanted to Nude Mice--With Special Reference to Administration Method of Anticancer Agents / S.Iida et al. / p561~561
General Lecture 279.Effects of MMC and 5FU on Nine Different Transplantable Strains of Humans Stomach Carcinomas in Nude Mice and the Results of Follow-up Studies on the Patients with Their Original Carcinomas / N.Miyagi et al. / p562~562
General Lecture 280.Characterization of a Cell Line(SGF-3)Derived from a Human Esophageal Carcinoma / T.Shinbo et al. / p562~562
General Lecture 281.Effects of Anticancer Drugs on Colony Formation of Cells from Cancer Tissue / T.Wada et al. / p563~563
General Lecture 282.Drug Sensitivity Test of Cultured Human Renal Cell Carcinomas by Regrowth Assay / T.Osawa et al. / p563~563
General Lecture 283.The Effect of Anticancer Drugs on Cell Cycle Progression in Human Bladder Cancer Cell Lines / O.Hashimoto et al. / p564~564
General Lecture 284.A Study on Sensitivity Testing of Ovarian Cancer Cells to Anticancer Chemotherapy--With Special Reference to Use of LDH and Its Isozymes as Indicators / H.Inui et al. / p564~564
General Lecture 285.Effect of Anti-AFP-daunomycin(DAM)Conjugate on the Growth of AFP Producing c-Hc-4 Cells / F.Sasaki et al. / p565~565
General Lecture 286.Effects of Bleomycin and Actinomycin D on a B-lymphoma Cell Line / M.Nishikori et al. / p565~565
General Lecture 287.Sensitivity of Four Bladder Cancer Cell Lines to Anticancer Drugs in vitro / H.Afuso et al. / p566~566
General Lecture 288.Not Received / /
General Lecture 289.A Preliminary Study for the Chemosensitivity Test Utilizing the Primary Short Term Culture with ³H-Thymidine / J.T.Chen et al. / p566~566
General Lecture 290.Experience of Preoperative Chemotherapy in Cancer of the Breast / K.Komuro et al. / p567~567
General Lecture 291.Histological Evaluation of Chemotherapy Effect for Preoperative Administration in Rectal Cancer / A.Ouchi et al. / p567~567
General Lecture 292.Histological Alterations in Esophageal Carcinoma by Bleomycin One-shot Arterial Injection with Special Reference to Nuclear DNA Conent / K.Maruta et al. / p568~568
General Lecture 293.Cytohistological Studies on the Effect of Long-term Maintenance chemotherapy / K.Yamamoto et al. / p568~568
General Lecture 294.Preoperative Treatment with OMF for Gastric Cancer / M.Mukai / p569~569
General Lecture 295.The Effects of Anticancerous Agents(Tegafur,UFT)Administered Preoperatively on Gastric Cancer / K.Okada et al. / p569~569
General Lecture 296.Relationship between Histological Changes of Gastric Cancer Receiving 5-FU Emulsion and Prognosis of the Patients / N.Mizuguchi et al. / p570~570
General Lecture 297.The Examination of Preoperative Chemotherapy for Gastric Cancer / K.Suzuki et al. / p570~570
General Lecture 298.Ultrastrural study on the Effects of Chemotherapy Applied to Human Gastric Cancer Cells / M.Sakaguchi et al. / p571~571
General Lecture 299.Fundamental Study on Depot-type Adriamycin Containing Contrast Medium for X-ray Examination / T.Okawa et al. / p571~571
General Lecture 300.The Local Therapy for Early Cervical Cancer--Comparative Studies on the Curerate between the Suppositories Made of Bleomycin Alone and of Bleomycin with 5-Fluorouracil or Carboquone / A.Kimura et al. / p572~572
General Lecture 301.Local Chemotherapy of Recurrent Head and Neck Cancer Patient by Bleomycin Ointment Combined with Membrane Active Agent / T.Nakashima et al. / p572~572
General Lecture 302.A Clinical Study of Release-controlled MMC Needle-type Preparation for Topical Cancer Chemotherapy / M.Nakamura et al. / p573~573
General Lecture 303. A Method for Local Application of Anti-cancer Drugs Using Collagen as a Drug Delivery Devise with Slow Release / T.Kubota / p573~573
General Lecture 304.Intravesical Chemotherapy for Superficial Bladder Cancer / M.Moriyama et al. / p574~574
General Lecture 305.By-pass Operation with Combined Radio and Chemotherapy in Non-resectable Esophagus Cancer / K.Namatame et al. / p574~574
General Lecture 306.Operation and Local Chemotherapy of Esophageal Cancer,Especially Esophageal Intubation with Bleomycin Coated Tube / T.Tanaka et al. / p575~575
General Lecture 307.Treatment of Esophageal Carcinoma by Oral Administration of Sodium Polyacrylate(PANa)Kayaku and Oil Bleomycin / T.Kamano et al. / p575~575
General Lecture 308.Combined Treatment of Advanced Carcinoma of Common Bile Duct / T.Kamata et al. / p576~576
General Lecture 309.A Clinical Study on the Administration of Adriamycin-Emulsion into the Bile Duct / T.Ito et al. / p576~576
General Lecture 310.Fundamental and Clinical Studies on Endoscopic Injection of Methyl-CCNU Emulsion for Gastric Cancer / H.Fujiwara et al. / p577~577
General Lecture 311.Clinical and Labolatory Evaluation of Steroid & Anti-cancer Drug Infusion Therapy for Malignant Effusion / M.Takahashi et al. / p577~577
General Lecture 312.Experimental and Clinical Study of Liposome-entrapped Anticancer Drugs / M.Tachibana et al. / p578~578
General Lecture 313.Intra-arterial Infusion of Micro-encapsulated Mitomycin C in the Treatment of Advanced Carcinoma / Y.Tsuji et al. / p578~578
General Lecture 314.Microencapsulated Mitomycin C Therapy in Unresectable Hepatoma and Liver Metastases of Miscellaneous Cancer / J.Itoh et al. / p579~579
General Lecture 315.Therapeutic Effect of Chemoembolisation with Mitomycin-microcapsules(MM-mc)for Renal Cell Carcinoma / H.Kato / p579~579
General Lecture 316.Not Received / /
General Lecture 317.Preoperative Superselective Transcatheter Vesical Arterial Embolization with Anti-cancer Agent in Bladder Carcinomas / S.Kimura et al. / p580~580
General Lecture 318.Not Received / /
General Lecture 319.Transcatheter Arterial Embolization Combined with Arterial Infusion for Hepatic Malignancies / J.Okamura et al. / p580~580
General Lecture 320.Treatment of Tumors with Ferromagnetic Microembolization--Clinical-Evalution in Hepatoma and Renal Cell Carcioma / S. Hirota et al. / p581~581
General Lecture 321.Effect of Transcatheter Arterial Embolization on Hepatocellular Carcinoma Patients / K.Soga et al. / p581~581
General Lecture 322.Not Received / /
General Lecture 323.Bronchial Arterial Infusion(BAI)for Multiple Lung Metastasis of Renal Cell Carcinoma / N.Miyazawa et al. / p582~582
General Lecture 324.Integrated Regional Chemotherapy and Surgery of Bladder Cancer--Regional Chemotherapy Given by Intraarterial Infusion with Concomitant Hemodialysis and Hemoperfusion / S.Kamidono et al. / p582~582
General Lecture 325.Experience of Intra-arterial Chemotherapy in the Advanced Cancer of the Digestive Organs / S.Murakami et al. / p583~583
General Lecture 326.Balloon-occluded Arterial Infusion--A New Method for Administration of Anticancer Drugs / S.Takashima et al. / p583~583
General Lecture 327.Intra-aortic Infusion Chemotherapy for Locally Recurrent Carcinoma of the Rectum / K.Yoshikawa et al. / p584~584
General Lecture 328.Use of Arterial Infusion of Neocarzinostatin as a Treatment for Carcinoma of the Prostate / A.Imagawa et al. / p584~584
General Lecture 329.Chemotherapy for Hepatocellular Carcinoma / Y.Okuyama et al. / p585~585
General Lecture 330.Metastatic Liver Tumor of Breast Cancer Treated with Intra-arterial Administration of Adriamycin and 5FU--A Case Report / R.Hosotani et al. / p585~585
General Lecture 331.The Treatment of Unresectable Liver Cancer by the Intermittent Hepatic Artery Occlusion and Infusion Chemotherapy / T.Tarumi et al. / p586~586
General Lecture 332.Blood Flow of Hepatoma Measured by Infusion of Kr-81m and Xe-133 via Catheter into Hepatic Artery / Y.Sasaki et al. / p586~586
General Lecture 333.The Therapeutic Effects of One Shot Intraarterial Infusion of Anti-neoplastic Agents for Liver Cancers / H.Hirose et al. / p587~587
General Lecture 334.The Effect of BLM-MMC-Lentinan(B-M-L)Arterial Infusion Therapy on Esophageal Cancer with Hepatic Metastasis / K.Okuyama et al. / p587~587
General Lecture 335.Combination Chemotherapy against Inoperable Liver Cancer (Primary and Secondary) -Study on the MQF-OK Therapy Including Intra-arterial Administration of Mitomycin-C and Carboquone- / Y.Sakata et al. / p588~588
General Lecture 336.Combination Chemotherapy with Adriamycin,Vincristine,Ifosfamide,and Prednisolone in the Treatment of Advanced Non-Hodgkin's Lymphoma / H.Ueoka et al. / p588~588
General Lecture 337.Effect of Cyclic VAMP Therapy for Advanced Malignant Lymphoma / S.Fukuhara et al. / p589~589
General Lecture 338.Clinical Trial of Combination Chemotherapy(CVP)in Advanced Non-Hodgkin's Lymphoma / I.Tanaka et al. / p589~589
General Lecture 339.High Dose Methotrexate Therapy on Lung Cancer and Malignant Lymphoma / H.Taguchi et al. / p590~590
General Lecture 340.High Dose Methotrexate with Leucovorin Rescue in the Treatment of Malignant Lymphoma / K.Sampi et al. / p590~590
General Lecture 341.Phase II and III Study with Vindesine in 50 Patients with Hematologic Malignancies / Y.Kubota et al. / p591~591
General Lecture 342.Not Received / /
General Lecture 343.Preventive Therapy of Central Nervous System Involvement in Childhood Acute Lymphocytic Leukemia (ALL) / J.Mimaya / p591~591
General Lecture 344.NCVP Therapy for Relapse of Acute Non-lymphocytic Leukemia Resistant to DCMP Therapy / Y.Karitani et al. / p592~592
General Lecture 345.Pharmacokinetics of Behenoyl-ara-C(BHAC)and Its Clinical Effects in Acute Leukemia / T.Ueda et al. / p592~592
General Lecture 346.Combination Therapy of Aclacinomycin A and BH-AC in Previously Untreated Patients with Acute Non-lymphocytic Leukemia / K.Sampi et al. / p593~593
General Lecture 347.Not Received / /
General Lecture 348.C.A.F.and/or C.M.F.Chemotherapy for Advanced Breast Cancer / J.Hirose et al. / p593~593
General Lecture 349.CAF Therapy for Advanced and Recurrent Breast Cancer / K.Enomoto et al. / p594~594
General Lecture 350.Hormono-chemotherapy of Breast Cancer with Cyclophosphamide,Adriamycin and Prednisolone (CAP) / Y.Nakamura et al. / p594~594
General Lecture 351.ACOP Combination Chemotherapy Consisting of Adriamycin,Cyclophosphamide,Oncovin(Vincristine)and Predonisolone for Recurrent and Advanced Breast Cancer / I.Yokoyama et al. / p595~595
General Lecture 352.Effects of Adriamycin to the Recurrence of the Breast Cancer / S.Hosoe et al. / p595~595
General Lecture 353.Sequential Endocrine-chemotherapy for Advanced Breast Cancer / Y.Nomura et al. / p596~596
General Lecture 354.The Five-year End Results of Operated Breast Cancer Patients Treated by Prolonged Cyclic Chemotherapy Especially Four Drug Combination (FEMP) / K.Endo et al. / p596~596
General Lecture 355.Mitomycin C,Methotrexate,Vincristine(MMV)Combination Chemotherapy for Advanced Breast Cancer Refractory to Adriamycin / K.Kanda et al. / p597~597
General Lecture 356.Effects of Long-term Oral Administration of Anti-cancer Drug to the Patients Treated with Non-curative Operation / S.Soejima et al. / p597~597
General Lecture 357.Combination Chemotherapy(5FU,Adriamycin and ACNU)in Advanced Gastrointestinal Cancer / J.Ishiwata et al. / p598~598
General Lecture 358.Clinical Evaluation of Combination Chemotherapy of Aclacinomycin A(ACM)and 5-Fluorouracil(5Fu)for Advanced Carcinoma of Gastrointestinal Tract / K.Kikuchi et al. / p598~598
General Lecture 359.A Four Drug Combination(MACC)Chemotherapy for Advanced or Recurrent Malignant Tumor / T.Matsunaga et al. / p599~599
General Lecture 360.Chemotherapy of Advanced Gastric Cancer / T.Satomi et al. / p599~599
General Lecture 361.Adriamycin/Mitomycin/Futraful Combination Chemotherapy for Advanced Carcinoma of the Stomach / Y.Kondoh et al. / p600~600
General Lecture 362.Postoperative Adjuvant Chemo-therapy of Advanced Stomach Cancer / Y.Furuta et al. / p600~600
General Lecture 363.Multihospital Randomized Study: Adjuvant Chemotherapy with Mitomycin-C and Futraful for Gastric Cancer VI.Estimation of Five-year Survival Rate / T.Kondo et al. / p601~601
General Lecture 364.Not Received / /
General Lecture 365.FQC Chemotherapy for Primary Ovarian Cancer / I.Takamura et al. / p601~601
General Lecture 366.UFT-M Chemotherapy for Ovarian Cancer(No.1) / T.Miwa et al. / p602~602
General Lecture 367.CAPF Combination Chemotherapy and Second-look Operation for the Treatment of Recurrent and Disseminated Malignant Tumor of Ovary / J.Inagaki et al. / p602~602
General Lecture 368.Not Received / /
General Lecture 369.Evaluation of Delayed Surgery for Gestational Choriocarcinoma / T.Tsukahara et al. / p603~603
General Lecture 370.An Aspect of the Intravenous Drop Infusion of Adriamycin(Part1) / H.Masuda et al. / p603~603
General Lecture 371.Experience of Combined Chemotherapy in Non-seminomatous Testicular Cancer / Y.Maruyama et al. / p604~604
General Lecture 372.Combined Surgery and Chemotherapy in Treatment of Stage I,II Testicular Tumors / S.Arakawa et al. / p604~604
General Lecture 373.Clinical Evaluation of Vinblastine Sulfate(VBL)in Renal Cell Carcinoma / Y.Saitoh et al. / p605~605
General Lecture 374.A Clinical Trial of Combination Chemotherapy with VCR,BLM,MMC,FT-207 and OK-432 in Urothelial Tumor / S.Fujihiro et al. / p605~605
General Lecture 375.Clinical Effect of UFT on Bladder Tumor / H.Kumon et al. / p606~606
General Lecture 376.Combination Chemotherapy with Multiple Agents of VPM-CisCF for Urogenital Malignancies / T.Yamauchi et al. / p606~606
General Lecture 377.Clinical and Experimental Studies on the Immunotherapy with Intradermal Injections of OK-432 / T.Kudo et al. / p607~607
General Lecture 378.Effect of Intraperitoneal Administration of OK-432 in Patients with Ascitic Gynecologic Tumor / N.Umesaki et al. / p607~607
General Lecture 379.Effect of Hypertranfusion and OK-432 on Blood Granulocyte Recovery / T.Nomura et al. / p608~608
General Lecture 380.Influence of Surgical Trauma on Cell-mediated Immunity and Tumor Growth / H.Kaneko et al. / p608~608
General Lecture 381.Effects of Various Immunostimulators on Carcinogenesis in Rats by Administration of MNNG / H.Shimizu et al. / p609~609
General Lecture 382.Effect of Immunomodulators on Natural Killing Activity / T.Akao et al. / p609~609
General Lecture 383.Immunotherapeutic Effects of Immune RNA on Methylcholanthrene-induced Fibrosarcomas in Balb/c Heteromice / S. Nomi et al. / p610~610
General Lecture 384.Active Specific Immunotherapy with 3M KCI Solubilized TSTA from Methylcholanthrene-induced Murine Sarcoma / T. Tanaka et al. / p610~610
General Lecture 385.NK Cell Activity of Malignant Brain Tumor Patients Treated with Interferon / T.Arai et al. / p611~611
General Lecture 386.Therapeutic Effect of Interferon and Interferon Inducer(Poly ICLC)in the Malignant Brain Tumor / O. Nakamura et al. / p611~611
General Lecture 387.Pilot Study of Fibroblast Interferon in Human Metastatic Breast Cancer / K.Wakasugi et al. / p612~612
General Lecture 388.Clinical Studies of Human Lymphocyte Interferon(Hu-IFN-a)Combined with Radiotherapy,Chemotherapy and Immunotherapy for 6 Cancer Patients / T.Miyoshi et al. / p612~612
General Lecture 389.The Change of Nuclear DNA Distributions on Murine Neuroblastomas Treated with Interferon and Cyclophosphamide / T.Tanaka et al. / p613~613
General Lecture 390.Combination Therapy of Interferon and Cyclophosphamide on Murine Neuroblastoma / M.Tozawa et al. / p613~613
General Lecture 391.Immunotherapy with Levamisole for Hepatocellular Carcinoma / K.Hojo et al. / p614~614
General Lecture 392.Immunochemotherapy in the Treatment of Hepatocellular Carcinoma / M.Tomita et al. / p614~614
General Lecture 393.Studies on Preoperative Immunotherapy for Gastric Cancer--The Effect of Immunostimulant"Levamisole" for the Regional Lymphnode / T.Kobori et al. / p615~615
General Lecture 394.Immunochemotherapy of Gastric Cancer / F.Ono et al. / p615~615
General Lecture 395.Evaluation of Levamisole (LMS) against Advanced Gastrointestinal Cancer by Cooperative Study / A.Wakui et al. / p616~616
General Lecture 396.Analysis of Gastric and Colorectal Cancer Cases at Stages III,IV,and V in which Postoperative Treatment with PSK Plus 5-FUDS was Done for One Year or Longer / S.Saji et al. / p616~616
General Lecture 397.Postoperative Long-term Adjuvant Immunochemotherapy in Gastric Cancer Patients / M.Oride et al. / p617~617
General Lecture 398.Comparison Studies on MQF-OK Therapy and MFC Therapy against Inoperable Gastric Cancer / Y.Sakata et al. / p617~617
General Lecture 399.Clinical Evaluation of Postoperative Chemotherapy,Immunotherapy,Immunochemotherapy in Advanced Gastric Cancer (Concerning Noncurative Resection and Non Resected Cases) / T.Taira et al. / p618~618
General Lecture 400.Combination Immuno Chemotherapy of Inoperable Gastric Cancer with 5-FU,ACNU,OK-432 / M.Tatewaki et al. / p618~618
General Lecture 401.Evaluation of Direct Injection of OK-432into Hepatoma / S.Imaoka et al. / p619~619
General Lecture 402.Combination Therapy of Advanced Cancer of Digestive Organs with OK-432,MMC,PSK and FT-207 / T.Yamaguchi et al. / p619~619
General Lecture 403.Immunochemotherapy of Lung Cancer
Effects of OK-432 on Monocyte Functions / N.Noda et al. / p620~620
General Lecture 404.Not Received / /
General Lecture 405.Studies on the Treatment of Cancer with the Combined Chemotherapy and Immunotherapy / I.Shima et al. / p620~620
General Lecture 406.The Combination Therapy(Intratumoral Large Dose of OK-432,Irradiation and Chemotherapy)of the Cancer of Cervix Uteri / M.Saito / p621~621
General Lecture 407.Maintenance Immuno-Chemotherapy for Cervical Carcinoma--A Comparative Study of OK-432 and Levamizole / H.Taniguchi et al. / p621~621
General Lecture 408.Clinical Effect of Immunopotentiators in Uterine Cervical Cancer / K.Kanazawa et al. / p622~622
General Lecture 409.Study on Cellular Immune Reactivities in the Patients with Advanced Cervical Cancer after Treatments Part 3: Comparison Study between Non-immunotherapeutic and Immunotherapeutic Groups / K.Hasegawa et al. / p622~622
General Lecture 410.A Peripheral Monocytic Effect in Patients with Cervical Carcinoma Following Immunopotential Therapy / M.Kaneko et al. / p623~623
General Lecture 411.Applicability of Lentinan to the Adrenalectomized Patients with Advanced Breast Cancer: Fundamental Study on the Adrenalectomized Rats / A.Kosaka et al. / p623~623
General Lecture 412.Experience of Vitamine B6 Therapy for Gastrointestinal Malignancy as Host Defense Stimulator / H.Sugiura et al. / p624~624
General Lecture 413.Two Cases of Long Survival with Malignant Glioma Treated by Immunotherapy Using Lymphocytes sensitized with Tumor-specific Immune RNA / R.Mita et al. / p624~624
General Lecture 414.Gastric Cancer Therapy Combined with N-CWS Administration by Endoscopy / A.Matsumi et al. / p625~625
General Lecture 415.BCG Immunotherapy in Patients with Carcinoma of the Oral Cavity in Our Department / H.Fukazawa et al. / p625~625
General Lecture 416.Statistical Reviews on the Clinical Results of Advanced Cancer Patients Treated with an Extract from Human Tubercle Bacilli (Maruyama Vaccine,S.S.M.) (Report III) / K.Fujita et al. / p626~626
General Lecture 417.Immunochemotherapy with SSM,an Extract from Mycobacterium Tuberculosis Strain Aoyama B,in Advanced Cancer:Evaluation of Clinical Effects of SSM by a Double-blind Test / N.Nomura et al. / p626~626
General Lecture 418.Intraoperative Radiotherapy in the Treatment of Carcinoma of the Pancreas / M.Yasue et al. / p627~627
General Lecture 419.Intraoperative Irradiation Combined with Radical Resection for Cancer of the Head of the Pancreas / T.Hiraoka et al. / p627~627
General Lecture 420.Clinical Results of Fast Neutron Radiotherapy for Carcinoma of the Gastrointestinal Tracts / T.Ishikawa et al. / p628~628
General Lecture 421.A Judgment on the Histological Effects of Preoperative Irradiation for Advanced Gastric Carcinoma / H.Joko et al. / p628~628
General Lecture 422.Autopsy Cases of Radiotherapy of Inoperable Gastric Cancer / S.Takashima et al. / p629~629
General Lecture 423.Radiation Therapy of Malignant Obstructive Jaundice / Y.Hishikawa et al. / p629~629
General Lecture 424.The Observation of Early Reaction in Radiotherapy of Carcinoma of the Tongue / S.Matsuura et al. / p630~630
General Lecture 425.Interstitial Radiotherapy of the Tongue Cancer by Iridium-192 / M.Takeda et al. / p630~630
General Lecture 426.Analysis of Treatment in Carcinoma of the Mobile Tongue Regarding Local Control and Complications / S.Takinami et al. / p631~631
General Lecture 427.The Result of Radiotherapy of Nasopharyngeal Carcinoma / K.Nishiyama et al. / p631~631
General Lecture 428.Subjects of ¹³¹I Therapy for a Differentiated Type of the Thyroid Cancer with Distant Metastasis / M.Miyakawa et al. / p632~632
General Lecture 429.A Case of an Aged Lung Cancer Patient Treated with Repeated Intraoperative Irradiation / T.Nakatsu et al. / p632~632
General Lecture 430.Clinical Experiences of Treatment for Primary Lung Cancer by Fast Neutron / Y.Iino et al. / p633~633
General Lecture 431.Analysis on Preoperative Combined Bleomycin and Radiation Therapy for Esophageal Carcinoma / O.Tanaka et al. / p633~633
General Lecture 432.Therapeutic Results and Long Survival Factors of Patients with Esophageal Cancers Treated with Radiotherapy Alone / T.Nakano et al. / p634~634
General Lecture 433.The Analysis of 5 Years Survivors by Radiotherapy Alone / M.Hareyama et al. / p634~634
General Lecture 434.Bigger Dose Radiotherapy in Treatment of Glioblastoma / Y.Maehara et al. / p635~635
General Lecture 435.Lymphocytic Lymphoma Treated by Total Body Irradiation / T.Yamashita et al. / p635~635
General Lecture 436.Radiotherapy of Cancer of Prostate / T.Nagayama et al. / p636~636
General Lecture 437.Radiation Therapy of Carcinoma of the Vulva / T.Arai et al. / p636~636
General Lecture 438.Radiation Therapy of Uterine Cervical Cancer in Our Hospital / M.Hirono et al. / p637~637
General Lecture 439.Comparison with the Radiotherapy Complications between Non-recurrent Group and Recurrent Group of Uterine Cervix Cancer / E.So et al. / p637~637
General Lecture 440.Intracavitary Therapy of Uterine Carcinoma Using the Remotely Controlled Afterloading Unit(Gynatron)with Low Dose-rate Irradiation / Y.Tanaka et al. / p638~638
General Lecture 441.Investigation of Rectal Injury and Limiting Factors of RALS-therapy to Carcinoma of the Uterine Cervix / T.Inoue et al. / p638~638
General Lecture 442.Clinical Experiences with Californium C5-252 for Cervical Carcinoma / K.Fukuda et al. / p639~639
General Lecture 443.Use of CT in Radiation Treatment of Cervical Carcinoma: Evaluation of Nodal Metastases / C.Kanehira et al. / p639~639
General Lecture 444.Evaluation of the External Irradiation Using the Comformation Technique on the Uterine Carcinoma(2nd Report) / A.Murakami et al. / p640~640
General Lecture 445.Clinical Significance of the Computer Controlled Conformation Radiotherapy / T.Matsuda et al. / p640~640
General Lecture 446.Clinical Trial of Radioprotector YM-08310 / I.Takahashi et al. / p641~641
General Lecture 447.Modifying Effects of Defibrinatic Agents on Radiation to Malignant Tumor in Mice and Human / T.Miyoshi et al. / p641~641
General Lecture 448.Clinical Trial of Hypoxic Cell Radiosensitizer Misonidazole / I.Takahashi et al. / p642~642
General Lecture 449.Clinical Study of Misonidazole Used as Pretreatment for X-ray Therapy for Cancer of the Cervix Uteri / T.Kitamura et al. / p642~642
General Lecture 450.Response to Radiation of Human Hepatoblastoma Xenograft in Nude Mice / M.Tanabe et al. / p643~643
General Lecture 451.Prophylactic Effect of α-tocopherol on Intestinal Radiation Injury in Patient with Gynecologic Cancer / Y.Watanabe et al. / p643~643
General Lecture 452.Radiation-induced Cancer of the Head and Neck Lesion-analysis of Its Clinical Frequency / K.Ichikawa et al. / p644~644
General Lecture 453.Effect of Concomitant Use of Immunomodulator(OK-432 and/or PSK)on Advanced Lung Cancer (Squamous Cell Carcinoma and Adenocarcinoma)Treated with Radiation with Combined Chemotherapy / Y.Ogawa et al. / p644~644
General Lecture 454.Role of Host's Immunity in Experimental Radiotherapy on Syngeneic Solid Tumors Transplanted to BALB/c Mice / K.Tsuyuki et al. / p645~645
General Lecture 455.Effectiveness of Hyperthermo-Chemo-Radiotherapy for Treatment of Carcinoma / H.Kai et al. / p645~645
General Lecture 456.A case of Hyperthermotherapy which Showed Remarkable Efficacy in a Patient with Recurrent Gastric Cancer / H.Honma et al. / p646~646
General Lecture 457.Hyperthermic Treatment for the Bladder Tumor Effect of Hyperthermic Irrigation with Lidocaine-enriched Saline / S.Kiyotaki et al. / p646~646
General Lecture 458.Hyperthermic Treatment for the Bladder Cancer: Combined Hyperthermic Treatment with Futraful and Picibanil / I.Murahashi et al. / p647~647
General Lecture 459.Local Hyperthermia Treatment of Advanced Cancer / K.Tari et al. / p647~647
General Lecture 460.Hyperthermic Therapy of the Bladder Cancer / Y.Kubota et al. / p648~648
General Lecture 461.Clinical Application of Hyperthermia to Treatment for Carcinoma of the Cervix (Fundamental Study on the Uterine Cervix Heating Apparatus) / T.Miura et al. / p648~648
General Lecture 462.Histopathological Studies on the Effect of Hyperthermia for Cervical Cancer / T.Kagabu et al. / p649~649
General Lecture 463.Experimental Studies of Selective Hyperthermia Using Induction Heating / S.Yokogawa et al. / p649~649
General Lecture 464.The Treatment of Malignant Brain Tumors by a Radiofrequency Conductive Heating / C.H.Kim et al. / p650~650
General Lecture 465.Experimental Studies on Thermochemotherapy / J.Miyao et al. / p650~650
General Lecture 466.Combined Microwave (433 MHz,2450 MHz) and Radiation Therapy on Patients with Advanced Cancer / Y.Ohizumi et al. / p651~651
General Lecture 467.Clinical Evaluation of Combination Therapy of Localized Hyperthermia by Microwaves and Chemotherapy for Far-advanced Carcinomas / T.Saito et al. / p651~651
General Lecture 468.Thermotherapy in Combination with Radiotherapy for the Treatment of Radioresistant Tumors / M.Hiraoka et al. / p652~652
General Lecture 469.Experimental Studies on Topical Therapy for Bladder Carcinoma III.Microwave lrradiation Enhanced with Magnetically Controlled Ferrite Particles / H.Mori et al. / p652~652
General Lecture 470.Clinical Experiences of Hyperthermia Cancer Therapy with Microwave / J.Egawa et al. / p653~653
General Lecture 471.Total Body Hyperthermia Using Extracorporeal Circuit for Disseminated Cancer Patients / M.Maeta et al. / p653~653
General Lecture 472.Extracorporeally Induced Systemic Hyperthermia / N.Kato et al. / p654~654
General Lecture 473.Cardio-pulmonary Responses and Hematological Changes in Systemic Hyperthermia / M.Hosoi et al. / p654~654
General Lecture 474.Multi-disciplinary Cancer Treatments Including Extracorporeally Induced Systemic Hyperthermia / K.Ota et al. / p655~655
General Lecture 475.Not Received / /
General Lecture 476.Hormone Receptors in Human Breast Cancer / H.Sonoo et al. / p655~655
General Lecture 477.The Effect of Medroxyprogesterone Acetate(MAP)for Recurrent and Advanced Breast Cancer / T.Okumoto et al. / p656~656
General Lecture 478.Effects of Oral High Dose Administration of Medroxyprogesterone Acetate(MAP)and Hexestsol on the Postmenopausal Patients with Advanced Breast Cancer / M.Kitamura et al. / p656~656
General Lecture 479.Chemo-endocrine Therapy for Advanced Breast Cancer--A Combined Therapy with Tamoxifen,Tegafur and Cyclophosphamide / T.Wada et al. / p657~657
General Lecture 480.Relationship between Sex Steroid Hormone Receptors in Renal Cell Carcinoma and Patient Survival / E.Nakano et al. / p657~657
General Lecture 481.Prognosis of Anti-androgen Therapy and Clinico-pathological Observation in Prostatic Cancer / S.Hoshi et al. / p658~658
General Lecture 482.Endocrine Therapy for Prostatic Cancer / M.Maruoka et al. / p658~658
General Lecture 483.A Statistical and Clinical Study on Prostatic Carcinoma at Okayama University Hospital / T.Tsushima et al. / p659~659
General Lecture 484.Microwave Coagulation Therapy for Tumors / K.Tabuse et al. / p659~659
General Lecture 485.Results of Follow-up Work on Cervical Intraepithelial Neoplasis after CO₂ Laser Irradiation / K.Sakamoto et al. / p660~660
General Lecture 486.Endoscopic Laser Treatment of Gastrointestinal Tumors(The Fifth Report) / Y.Ito et al. / p660~660
General Lecture 487.Clinical Application of Nd-YAG Laser in Patients with Gastric and Lung Cancer / S.Suzuki et al. / p661~661
General Lecture 488.The Effect of Nd-YAG Laser on MNNG Induced Gastric Cancers in Rats / M.Sasako et al. / p661~661
General Lecture 489.Synergistic Effect of Intra Venous Hyperalimentation and Intra-arterial Infusion Cancer Chemotherapy / M.Inawashiro et al. / p662~662
General Lecture 490.Effect of Chemotherapy Combined with TPN as an Adjunct to an Operation of Advanced Gastric Cancer / N.Yamada et al. / p662~662
General Lecture 491.Effects of Parenteral Nutrition on the Metabolism of Chemotherapeutic Agent / M.Kimoto et al. / p663~663
General Lecture 492.Experimental Study on the Effects of IVH(Intravenous Hyperalimentation)and Chemotherapy upon the Tumor Growth / H.Shigeta et al. / p663~663
General Lecture 493.Use of Elemental Diet for Nutritional Management of the Patients with Head and Neck Tumors / A.Saito et al. / p664~664
General Lecture 494.Effect of Amino Acid Imbalanced Elemental Diet on the Growth of C3H Mouse Fibro Sarcoma / S.Usui et al. / p664~664
General Lecture 495.Plasmapheresis in Patients with Advanced Gynecological Malignancies / T.Kajino et al. / p665~665
General Lecture 496.Clinical Experience of Plasmapheresis in Patients with Advanced Cancer / T.Okumura et al. / p665~665
General Lecture 497.Plasmapheresis in Patients with Disseminated Cancer Studies on Immunological Parameters / H.Kono et al. / p666~666
General Lecture 498.Prognosis of Extranodal Lymphomas / Y.Tamaki et al. / p666~666
General Lecture 499.Malignant Lymphoma of the Nasal Cavity and Paranasal Sinus / S.Ushiro et al. / p667~667
General Lecture 500.Studies on the Clinical pictures of Malignant Lymphomas of the Thyroid / M.Miyakawa et al. / p667~667
General Lecture 501.Surgical Treatment for the Gastrointestinal Malignant Lymphoma / S.Ikeuchi et al. / p668~668
General Lecture 502.On the Significance of Multiagent Chemotherapy for Primary Gastric Malignant Lymphoma / T.Takenaka et al. / p668~668
General Lecture 503.Prognosis of Non-Hodgkin's Lympboma According to Pathological Classifications / M.Miyamoto et al. / p669~669
General Lecture 504."Silent"Brain Metastasis of Malignant Tumors / J.Uki et al. / p669~669
General Lecture 505.Successful Therapy of Cerebral Metastasis of Gestational Choriocarcinoma. A Case Report / T.Morizuka et al. / p670~670
General Lecture 506.CNS Metastases in Patients with Advanced Breast Cancer / T.Nagata et al. / p670~670
General Lecture 507.Result of the Treatment for Metastatic Brain Tumor / M.Kitahara et al. / p671~671
General Lecture 508.Evaluation of Conservative Treatment for Squamous Cell Carcinoma of the Oral Cavity,Except the Tongue / S.Makino et al. / p671~671
General Lecture 509.Lymph Nodes Metastases of Tongue Carcinomas / T.Watanabe et al. / p672~672
General Lecture 510.The Analysis of the Factors of Prognosis in Carcinoma of the Tongue / B.Satake et al. / p672~672
General Lecture 511.Malignant Hemangiopericytoma of the Mandibular Alveolar Process--A Case Report / Y.Endoh et al. / p673~673
General Lecture 512.Local Treatment for Recurrence of Head and Neck Cancer / K.Inoue et al. / p673~673
General Lecture 513.Treatment of Advanced Aged Patients over 80 with Head and Neck Cancers / K.Yoshino et al. / p674~674
General Lecture 514.Bleo-VEMF'HA(BLM,VCR,EX,MTX,FH,Predonin and ADM) Synchronized Chemotherapy,and Its Modified Chemotherapy(Used CQ Instead of EX) / M.Ohkawa et al. / p674~674
General Lecture 515.The Operations Limit and More Wide Technic of the Advanced Thyroid Surgery / H.Goto et al. / p675~675
General Lecture 516.Factors Influencing on the Survival in Operated Thyroid Carcinoma / H.Nakajima et al. / p675~675
General Lecture 517.The Experimental Study on the Suppressive Effect for the Pulmonary Metastasis of the Arterial-infusion of Adriamycin / A.kato et al. / p676~676
General Lecture 518.Treatment of Pulmonary Metastasis of Osteosarcoma / S.Yamawaki et al. / p676~676
General Lecture 519.Treatment of Recurrent and Metastatic Bone and Soft Tissue Tumors / S.Yoh et al. / p677~677
General Lecture 520.Surgical Therapy of Lung Cancer: Results of Palliative Resection / I.Takagi et al. / p677~677
General Lecture 521.Evaluation of Limited Operation for Lung Cancer / K.Shibata et al. / p678~678
General Lecture 522.Treatment of the Intolerable Pain in Far-advanced Lung Cancer--Effects of the Brompton Mixture / k.Ninomiya et al. / p678~678
General Lecture 523.Cancer in Remnant Stomach (Mainly on Resected Cases) / T.Imada et al. / p679~679
General Lecture 524.Therapy of pm Gastric Cancer / H.Nomura.et al. / p679~679
General Lecture 525.The Three and Five Years Survival Rates for Gastric Cancer after Gastrectomy / N.Tajima et al. / p680~680
General Lecture 526.Treatment of Gastric Cancer in the High Aged / H.Umemura et al. / p680~680
General Lecture 527.Surgical Treatment and Combined Radiotherapy for Esophageal Carcinoma / H.Otani et al. / p681~681
General Lecture 528.Treatment of"Early"and"Superficial"Esophageal Cancer / K.Koseki et al / p681~681
General Lecture 529.Postoperative Complication and Complaint of Transabdominal Resection of Esophagocardial Cancer with By-pass Method / Y.Miyoshi et al. / p682~682
General Lecture 530.Examinations of the Resected Cases by Pancreaticoduodenectomy with Resection of the Portal Vein in Periampullary Cancer / R.Ohyama et al. / p682~682
General Lecture 531.Carcinoma of the Extrahepatic Bile Ducts--A Histopathologic Study / K.Shinmura et al. / p683~683
General Lecture 532.Diagnosis and Treatment for Cholangiocellular Carcinoma of the Liver / T.Sanda et al. / p683~683
General Lecture 533.Clinicopathological Studies of Minute Hepatocellular Carcinoma--Analysis of 7 Resected Cases / T.Yoshikawa et al. / p684~684
General Lecture 534.Postoperative Care of Hepatectomized Patients--Clinical Application of Metabolic Liver Assist / Y.Kono et al. / p684~684
General Lecture 535.Surgical Treatment to the Recurrence of the Rectal Carcinoma / H.Eguchi et al. / p685~685
General Lecture 536.Clinicopathological Study on Combined Resection of the Adjacent Organs for Colorectal Cancer / T.Sekine et al. / p685~685
General Lecture 537.Long Survivals Following Total Pelvic Exenteration for Advanced Rectal Cancer / H.Takagi et al. / p686~686
General Lecture 538.Therapy of Carcinoids of the Large Intestine / M.Kameyama et al. / p686~686
General Lecture 539.Management of Advanced Bladder Carcinoma / M.Iguchi et al. / p687~687
General Lecture 540.Multidisciplinary Treatment of Advanced Bladder Cancer / Y.Matsumura et al. / p687~687
General Lecture 541.Total Cystectomy for Bladder Cancer and Its Prognosis / T.Igarashi et al. / p688~688
General Lecture 542.Statistical Studies on Partial Cystectomy for Bladder Cancer / T.Kobayashi et al. / p688~688
General Lecture 543.Treatment of Carcinoma of the Urachus / T.Kakizoe et al. / p689~689
General Lecture 544.Clinical Management of Carcinoma in Situ of the Bladder / H.Itatani / p689~689
General Lecture 545.Operative Treatment of the Bladder Cancer: Clinical Aspects of the Carcinoma in Situ / M.Nakazono et al. / p690~690
General Lecture 546.Prognosis of Low Grade,Low Stage Carcinoma of the Bladder / T.Miura et al. / p690~690
General Lecture 547.lndication of Therapeutic Conization to Early Cervical Cancer and Fertility after Treatment / S.Moriya et al. / p691~691
General Lecture 548.Reproductive Performance of Women after Chemotherapy of Trophoblastic Disease / N.Shinkai et al. / p691~691
General Lecture 549.Experimental Study on Urethral Disorders after Operation of Cervical Cancer / A.Kurokawa et al. / p692~692
General Lecture 550.Neutrophils Function in Post Operative Retroperitoneal Space Exudate after Radical Hysterectomy for Cervical Cancer / A.Ito et al. / p692~692
General Lecture 551.Ways to Prevent Complications of Pelvic Exenteration / N.Tsukamoto et al. / p693~693
General Lecture 552.Therapeutic Limits of Local Treatment (Radical Hysterctomy and Pelvic Lymphnode Dissection) -Necessity of Additional Systemic Therapy in the Uterine Cervical Cancer- / H.Masaoka et al. / p693~693
General Lecture 553.Malignant Ovarian Tumors in Young Women / M.Yamasaki et al. / p694~694
General Lecture 554.Not Received / /
General Lecture 555.Effects of Chemotherapy and Surgical Treatment on Choriocarcinoma / T.Maruo et al. / p694~694
General Lecture 556.Surgical Management in the Primary Management of Hydatidiform Mole / K.Kawagoe et al. / p695~695
General Lecture 557.Effects of Chemotherapy and Surgical Treatment on Invasive Mole / A.Harada et al. / p695~695
General Lecture 558.Studies on 106 Cases of Hydatidiform Mole(HM)Interrupted and Followed up in Our Hospital / T.Hando et al. / p696~696
「国立国会図書館デジタルコレクション(雑誌)」より
書名
日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology